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 1 
ABSTRACT 1 
Sphingobium sp. strain SYK-6 converts four stereoisomers of arylglycerol--guaiacyl 2 
ether into achiral -hydroxypropiovanillone (HPV) via three stereospecific reaction 3 
steps. Here we determined the HPV catabolic pathway and characterized the HPV 4 
catabolic genes involved in the first two steps of the pathway. In SYK-6 cells, HPV was 5 
oxidized to vanilloyl acetic acid (VAA) via vanilloyl acetaldehyde (VAL). The resulting 6 
VAA was further converted into vanillate through the activation of VAA by coenzyme 7 
A. A syringyl-type HPV analog, -hydroxypropiosyringone (HPS), was also catabolized 8 
via the same pathway. SLG_12830 (hpvZ), which belongs to the glucose-methanol-9 
choline oxidoreductase family, was isolated as the HPV-converting enzyme gene. An 10 
hpvZ mutant completely lost the ability to convert HPV and HPS, indicating that hpvZ is 11 
essential for the conversion of both the substrates. HpvZ produced in Escherichia coli 12 
oxidized both HPV and HPS, and other 3-phenyl-1-propanol derivatives. HpvZ 13 
localized to both the cytoplasm and membrane of SYK-6 and used ubiquinone 14 
derivatives as electron acceptors. Thirteen gene products of the 23 aldehyde 15 
dehydrogenase (ALDH) genes in SYK-6 were able to oxidize VAL into VAA. Mutant 16 
analyses suggested that multiple ALDH genes, including SLG_20400, contribute to the 17 
conversion of VAL. We examined whether the genes encoding feruloyl-CoA synthetase 18 
(ferA) and feruloyl-CoA hydratase/lyase (ferB and ferB2) are involved in the conversion 19 
of VAA. Only FerA exhibited activity toward VAA; however, disruption of ferA did not 20 
affect VAA conversion. These results indicate that another enzyme system is involved in 21 
VAA conversion.  22 
 2 
IMPORTANCE 23 
Cleavage of the -aryl ether linkage is the most essential process in lignin 24 
biodegradation. Although the bacterial -aryl ether cleavage pathway and catabolic 25 
genes have been well documented, there have been no reports regarding the catabolism 26 
of HPV or HPS, the products of cleavage of -aryl ether compounds. HPV and HPS 27 
have also been found to be obtained from lignin by chemoselective catalytic oxidation 28 
by 2,3-dichloro-5,6-dicyano-1,4-benzoquinone/tert-butyl nitrite/O2, followed by 29 
cleavage of the -aryl ether with zinc. Therefore, value-added chemicals are expected to 30 
be produced from these compounds. In this study, we determined the SYK-6 catabolic 31 
pathways for HPV and HPS, and identified the catabolic genes involved in the first two 32 
steps of the pathways. Since SYK-6 catabolizes HPV through 2-pyrone-4,6-33 
dicarboxylate, which is a building block for functional polymers, characterization of 34 
HPV catabolism is important not only for understanding the bacterial lignin catabolic 35 
system but also for lignin utilization. 36 
 37 
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INTRODUCTION 41 
Lignin, one of the major components of plant cell walls, is a complex phenolic 42 
heteropolymer produced from hydroxycinnamyl alcohols by radical coupling (1, 2). 43 
Lignin is the second most abundant bioresource on earth after cellulose and is expected 44 
to be used as an industrial raw material. However, the current industrial applications of 45 
lignin are limited to low value applications such as production of solid fuels and 46 
concrete additives (3, 4). On the other hand, it has been reported that the building blocks 47 
for functional polymers, such as 2-pyrone-4,6-dicarboxylic acid (5-7), cis,cis-muconic 48 
acid (8-10), and medium chain-length polyhydroxyalkanoic acid (11), can be obtained 49 
from lignin-derived aromatic compounds such as vanillic acid, vanillin, ferulic acid, and 50 
p-coumaric acid through microbial catabolism. Therefore, production of value-added 51 
chemicals from lignin through transformations systems that consist of chemical lignin 52 
decomposition and microbial catabolism of lignin-derived aromatics has attracted 53 
attention. 54 
-Aryl ether is the most abundant linkage in lignin, comprising 45%–50% of all 55 
linkages in softwood lignin and 60%–62% in hardwood lignin (4). Accordingly, 56 
degradation of this structure is considered a crucial step in lignin biodegradation. -Aryl 57 
ether-type biaryls have two distinct isomeric forms, erythro and threo, each of which 58 
has enantiomeric forms (12). To date, the whole picture of the enzyme system for the 59 
cleavage of -aryl ether in Sphingobium sp. strain SYK-6 has been determined (13). 60 
SYK-6 is able to degrade all the stereoisomers of -aryl ether-type biaryl, 61 
guaiacylglycerol--guaiacyl ether (GGE). In SYK-6 cells, four stereoisomers of GGE 62 
are converted to two enantiomers of -(2-methoxyphenoxy)--hydroxypropiovanillone 63 
(MPHPV) through the oxidation of the GGE -carbon atom catalyzed by C-64 
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dehydrogenases (LigD, LigL, and LigN) (Fig. 1) (14). LigD oxidizes (R,S)-GGE and 65 
(R,R)-GGE into (S)-MPHPV and (R)-MPHPV, respectively, while LigL/LigN 66 
converts (S,R)-GGE and (S,S)-GGE into (R)-MPHPV and (S)-MPHPV, 67 
respectively (14). The ether linkage of the resulting MPHPV is cleaved by 68 
enantioselective glutathione S-transferases (GSTs), LigF, LigE, and LigP, to produce -69 
glutathionyl--hydroxypropiovanillone (GS-HPV) and guaiacol via nucleophilic attack 70 
of glutathione on the MPHPV -carbon atom (15, 16). LigF and LigE/LigP attack (S)-71 
MPHPV and (R)-MPHPV to produce (R)-GS-HPV and (S)-GS-HPV, respectively. 72 
Another GST, LigG, catalyzes the cleavage of the thioether linkage in (R)-GS-HPV by 73 
transferring glutathione of (R)-GS-HPV to another glutathione molecule to produce 74 
HPV and glutathione disulfide (15, 17). On the other hand, LigG had little to no activity 75 
with (S)-GS-HPV, suggesting involvement of an alternative GST in the conversion of 76 
(S)-GS-HPV (15, 18). Recently, further detailed biochemical characterization of the -77 
aryl ether catabolic enzymes of SYK-6 and their orthologs in other bacterial strains, and 78 
structural analyses of LigD, LigL, LigE, LigF, and LigG have been performed (17-29). 79 
In addition, Erythrobacter sp. strain SG61-1L and Novosphingobium sp. strain 80 
MBES04, which are capable of cleaving -aryl ether, have recently been isolated, and 81 
similar enzyme systems have been characterized (23, 24). 82 
Although many investigations of the cleavage of -aryl ether have been 83 
performed, there are no reports on the characterization of the catabolism of HPV, the 84 
product of the cleavage of -aryl ether. Therefore, for understanding bacterial -aryl 85 
ether catabolism, it is essential to elucidate the HPV catabolic system. Recently, the 86 
production of HPV and -hydroxypropiosyringone (HPS; an intermediate metabolite of 87 
syringyl-type -aryl ether) from lignin has been attempted through biological and 88 
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chemical processes for the purpose of obtaining phenolic monomers from lignin (27, 89 
30). Ohta et al. reported that HPV and HPS could be obtained from milled wood lignin 90 
from Japanese cedar (Cryptomeria japonica) and Eucalyptus globulus after reactions 91 
with MBES04 enzymes (27). Lancefield et al. reported an isolation method for HPV 92 
and HPS from Birch lignin via catalytic oxidation of the -aryl ether linkage in lignin 93 
followed by zinc-mediated cleavage of the ether bonds (30). By combining these 94 
decomposition methods with microbial catabolism of HPV and HPS, development of a 95 
production system for value-added chemicals from lignin is expected. 96 
In this study, we determined the catabolic pathway of HPV and HPS in SYK-6, 97 
and characterized the genes involved in the first two steps of the pathway.  98 
 6 
RESULTS AND DISCUSSION 99 
Determination of the pathway for the catabolism of HPV and HPS in Sphingobium 100 
sp. SYK-6. In order to determine the catabolic pathway of HPV in SYK-6, intermediate 101 
metabolites generated during the incubation of HPV with resting cells of SYK-6 were 102 
identified. Resting cells of SYK-6 grown in Wx minimal medium (31) containing 10 103 
mM sucrose, 10 mM glutamate, 0.13 mM methionine, and 10 mM proline (Wx-SEMP) 104 
were incubated with 1 mM HPV for 6 h, and the reaction mixtures were analyzed by 105 
high-performance liquid chromatography-mass spectrometry (HPLC-MS). This analysis 106 
indicated that HPV was converted into compound I with a retention time of 3.1 min 107 
(Fig. 2B). Based on a comparison of the retention time and m/z value of the 108 
deprotonated ion of compound I with those of the authentic sample, this compound was 109 
identified as vanillic acid (molecular weight [Mw], 168) (Fig. 2C and Fig. S1A and B). 110 
Next, a cell extract (>10 kDa) of SYK-6 cells grown in Wx-SEMP was incubated with 111 
200 µM HPV for 24 h. HPLC-MS analysis of the reaction mixture showed that HPV 112 
was converted into compound II with a retention time of 2.9 min (Fig. 2E). Positive 113 
electrospray ionization (ESI)-MS analysis of compound II showed a major fragment at 114 
m/z 298 (Fig. 2F). Based on the molecular weight deduced from the major fragment ion 115 
and additives in the reaction mixture, compound II was identified as an imine derivative 116 
of vanilloyl acetaldehyde (VAL), 2-((3-hydroxy-3-(4-hydroxy-3-117 
methoxyphenyl)allylidene)amino)-2-(hydroxymethyl)propane-1,3-diol or its 118 
oxazolidine product (VAL-Tris; Mw, 297; Fig. S1C and D). It is known that some 119 
aldehyde substrates such as glyceraldehyde 3-phosphate, acetaldehyde, and 120 
benzaldehyde react with tris(hydroxymethyl)aminomethane (Tris) to form imine 121 
product, which is then trapped by one of the free hydroxyl groups forming an 122 
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oxazolidine product (32). Furthermore, Fukuzumi et al. attempted to synthesize VAL by 123 
Claisen-Wislicenus hydroxymethylene condensation between acetovanillone and ethyl 124 
formate in the presence of metallic sodium; however, cis-vanilloyl vinyl alcohol, a 125 
tautomer of VAL, was obtained as a major product (33). It was thought that VAL had 126 
five possible tautomers, and the form of hydroxyl vinyl ketone structure (vanilloyl vinyl 127 
alcohol) was stable (33). These observations suggested that VAL-Tris (imine product) 128 
was produced from HPV through oxidation of Calcohol catalyzed by the SYK-6 cell 129 
extract to generate VAL, and to result in the isomerization of VAL and condensation 130 
between a VAL isomer and Tris in the reaction buffer. VAL-Tris (imine product) was 131 
then possibly converted to the oxazolidine product. 132 
When a SYK-6 cell extract (>10 kDa) was incubated with 200 µM HPV in the 133 
presence of 500 µM NAD+ for 2 h, an accumulation of compound III with a retention 134 
time of 4.7 min was observed (Fig. 2G). Negative ESI-MS analysis of compound III 135 
showed fragments at m/z 209 and 165 (Fig. 2I). Since these fragments seemed to 136 
represent the deprotonated ion and its decarboxylated ion, respectively compound III 137 
was identified to be vanilloyl acetic acid (VAA; Mw, 210; Fig. S1E and F). VAL seems 138 
to be transformed to VAA by NAD+-dependent aldehyde dehydrogenase(s) (ALDHs) 139 
(Fig. 1). Additionally, when the same reaction mixture was incubated for 24 h, 140 
compound IV with a retention time of 5.8 min was generated (Fig. 2H). A comparison 141 
of the retention time and m/z value of the protonated ion with those of the authentic 142 
sample indicated that compound IV was acetovanillone (Mw, 166; Fig. 2L and Fig. S1G 143 
and H). Previously, Niwa and Saburi reported that VAA was spontaneously 144 
decarboxylated to acetovanillone (Fig. 1) (34). 145 
Because lignin-derived aromatic acids such as ferulate, p-coumarate, and caffeate 146 
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are catabolized via CoA-dependent pathways, we predicted that VAA is catabolized 147 
through its Cactivation by coenzyme A (CoA) (35-39). A SYK-6 cell extract (>10 148 
kDa) was therefore incubated with 200 µM HPV in the presence of 500 µM NAD+, 2 149 
mM CoA,2.5 mM MgSO4, and 2.5 mM ATP. After incubation for 2 h, a decrease in 150 
HPV and an accumulation of VAA (compound III) were observed (Fig. 2J). After further 151 
incubation for 24 h, vanillic acid (compound I) and acetovanillone (compound IV) were 152 
observed (Fig. 2K). Vanillic acid was generated only when CoA, ATP, and MgSO4 were 153 
present. This result strongly suggested that VAA was converted to vanillate through the 154 
CoA derivative of VAA (Fig. 1). 155 
Similarly, we examined the SYK-6 catabolic pathway of HPS. Resting SYK-6 156 
cells grown in Wx-SEMP were incubated with 1 mM HPS for 4 h, and the reaction 157 
mixtures were analyzed by HPLC-MS. This analysis indicated that HPS was converted 158 
into compound V with a retention time of 2.6 min (Fig. 3B). Negative ESI-MS analysis 159 
of compound V showed a major fragment at m/z 197 (Fig. 3C). Based on a comparison 160 
of the retention time and m/z value of the deprotonated ion with those of the authentic 161 
sample, compound V was identified as syringic acid (Mw, 198; Fig. S1I and J). In order 162 
to clarify the more detailed catabolic pathway of HPS, cell extracts (>10 kDa) prepared 163 
from SYK-6 cells grown in Wx-SEMP were incubated with 200 µM HPS for 16 h. An 164 
accumulation of compound VI with a retention time of 1.8 min was observed (Fig. 3E). 165 
Negative ESI-MS analysis of compound VI showed a major fragment at m/z 326 (Fig. 166 
3F), suggesting the formation of an imine derivative of 3-(4-hydroxy-3,5-167 
dimethoxyphenyl)-3-oxopropanal (designated SAL), 2-((3-hydroxy-3-(4-hydroxy-3,5-168 
dimethoxyphenyl)allylidene)amino)-2-(hydroxymethyl)propane-1,3-diol or its 169 
oxazolidine product (SAL-Tris; Mw, 327). 170 
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In the presence of 500 µM NAD+, the same cell extract (>10 kDa) converted HPS 171 
into SAL-Tris (compound VI) and compound VII with a retention time of 3.3 min (Fig. 172 
3H). Negative ESI-MS analysis of compound VII showed fragments at m/z 239 and 173 
195, which seemed to represent the deprotonated ion and its decarboxylated ion, 174 
respectively (Fig. 3I). From these results, compound VII was identified as 3-(4-175 
hydroxy-3,5-dimethoxyphenyl)-3-oxopropanoic acid (designated SAA; Mw, 240). 176 
These results indicate that HPS was oxidized to SAA via SAL, and may be degraded by 177 
the same enzyme system involved in HPV catabolism (Fig. 1). 178 
  179 
Basic properties of the enzyme involved in the conversion of HPV. In order to 180 
characterize the enzymes involved in the catabolism of HPV in SYK-6, cofactor 181 
requirements and induction profiles of the HPV-transforming activities in SYK-6 were 182 
examined. The effects of the addition of 1-methoxy-5-methylphenazinium methylsulfate 183 
(PMS), flavin adenine dinucleotide (FAD) + PMS, and NAD+ on the enzyme activities 184 
in converting 200 µM HPV were investigated. When an extract of SYK-6 cells grown in 185 
Wx-SEMP was incubated with HPV in the presence of PMS, the extract showed 1.8-186 
fold higher activity (4.2 ± 0.7 nmolmin–1mg–1) than that in the absence of cofactors 187 
(2.4 ± 0.8 nmolmin–1mg–1). On the other hand, the addition of FAD or NAD+ had no 188 
effect on the activity. These results suggested that an oxidase(s) that requires an electron 189 
acceptor is involved in HPV oxidation. The HPV-oxidizing activity of an extract of 190 
SYK-6 cells grown with GGE was also measured in the presence of PMS. However, no 191 
activation was observed, suggesting the constitutive expression of the gene(s) 192 
responsible for the oxidation of HPV. 193 
 194 
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Isolation of the gene involved in the conversion of HPV. A cosmid library of 195 
SYK-6 constructed in Sphingomonas sanguinis IAM 12578 was screened for clones 196 
capable of degrading HPV. Of the 1,000 clones tested, three transconjugants degraded 197 
HPV, and cosmids pSA53, pSA88, and pSA684 were isolated. Southern hybridization 198 
analysis of the cosmid clones using SalI-digested pSA53 as a probe suggested that a 3.6 199 
kb, a 2.0 kb, and two 1.0 kb SalI fragments were commonly present in the above 200 
cosmids. Subcloning and nucleotide sequencing showed that these SalI fragments were 201 
present in a 17.9 kb DNA fragment that contained 13 genes corresponding to 202 
SLG_12790 through to SLG_12910. In this fragment, SLG_12830 revealed 36%–39% 203 
amino acid sequence identity with the glucose-methanol-choline (GMC) oxidoreductase 204 
family enzymes, including 3-(2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-205 
methoxy-2,3-dihydrobenzofuran-5-yl)acrylic acid (DCA-C) oxidases (PhcC and PhcD) 206 
involved in the catabolism of dehydrodiconiferyl alcohol (DCA) in SYK-6 (40), AlkJ, 207 
which is involved in the oxidation of primary alcohols to aldehydes in Pseudomonas 208 
putida GPo1 (41), and polyethylene glycol dehydrogenase (PegA) of Sphingopyxis 209 
terrae (42). 210 
 211 
The gene product of SLG_12830 catalyzes oxidation of HPV. SLG_12830 212 
fused with a His tag at the 5 terminus was co-expressed in E. coli with the trigger factor 213 
chaperone. Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) 214 
of a cell extract prepared from E. coli harboring pCold12830 and pTf16 (hpvZ-215 
expressing E. coli) showed the expression of SLG_12830 (Fig. S2). In order to 216 
determine the reaction product, resting cells of the E. coli transformant were incubated 217 
with 200 µM HPV in Tris-HCl buffer. HPLC-MS analysis showed that HPV was almost 218 
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completely converted, and that VAL-Tris and compound VIII with a retention time of 219 
5.4 min were produced (Fig. 4A). When the same incubation was performed in water, a 220 
significant amount of compound VIII was observed without the generation of VAL-Tris 221 
(Fig. 4B). Positive ESI-MS analysis of compound VIII showed a major fragment at m/z 222 
195 (Fig. 4C), suggesting that compound VIII was VAL (Mw, 194). These results 223 
indicated that the gene product of SLG_12830 has the ability to oxidize HPV into VAL. 224 
 225 
Role of SLG_12830 in HPV and HPS catabolism. In order to examine whether 226 
SLG_12830 is indeed involved in the conversion of HPV in SYK-6, an SLG_12830 227 
mutant (SME059) was created (Fig. S3A and B). The ability of SME059 to convert 228 
HPV was assessed using resting cells. SME059 was no longer able to convert HPV, 229 
whereas the wild type completely converted 200 µM HPV within 3 h (Fig. 4D). When 230 
GGE was used as a substrate, the conversion rates of the wild type and SME059 were 231 
almost identical (Fig. 4E). However, only SME059 accumulated HPV at a concentration 232 
approximately equimolar to the added GGE (Fig. 4E). In addition, SME059 also 233 
completely lost the ability to convert HPS (Fig. 4F). The HPV conversion defect of 234 
SME059 was complemented by the introduction of pJB12830 carrying SLG_12830 235 
(Fig. 4G). These results demonstrated that GGE is catabolized through HPV in SYK-6, 236 
and SLG_12830 is essential for the catabolism of HPV and HPS; thus, we designated 237 
this gene hpvZ. 238 
 239 
Cellular localization of HpvZ. In order to determine the cellular localization of 240 
HpvZ, HPV-transforming activities of soluble and membrane fractions of SYK-6 cells 241 
were compared. The HPV transforming activity in the cytoplasmic and membrane 242 
 12 
fractions were estimated to be 0.6 ± 0.1 nmolmin–1 (7.5 mg of protein) and 0.5 ± 0.1 243 
nmolmin–1 (0.9 mg of protein), respectively, based on the results that the ratio of the 244 
amount of proteins in the soluble and membrane fractions was 75:9.4 (40). These results 245 
indicated that HpvZ is localized to cytoplasm and cytoplasmic membrane. Similarly, 246 
GMC oxidoreductase family proteins, PhcC and PhcD from SYK-6, and PegA from S. 247 
terrae, have been suggested to localize to both the soluble and membrane fractions (40, 248 
43). Another GMC oxidoreductase family protein, AlkJ from P. putida GPo1, and 249 
glucose dehydrogenase from Pseudomonas fluorescens, were localized to the membrane 250 
(41, 44). Since there are no predicted signal sequences or hydrophobic transmembrane 251 
segments in the deduced amino acid sequence of HpvZ, this enzyme appears to be a 252 
peripheral cytoplasmic membrane protein like other membrane-associated GMC 253 
oxidoreductase family enzymes. 254 
 255 
Enzyme properties of HpvZ. Cell extracts prepared from hpvZ-expressing E. 256 
coli were fractionated into the soluble and membrane fractions. SDS-PAGE of both 257 
fractions showed the expression of hpvZ (Fig. S2). The specific activity for HPV of the 258 
membrane fraction was estimated to be 26 ± 6 nmolmin–1mg–1. However, the soluble 259 
fraction showed no activity even in the presence of PMS. The membrane fraction was 260 
treated with each of ten different detergents, and the solubilized HpvZ was obtained 261 
from the membrane fractions treated with n-dodecylphosphocholine and 5-cyclohexyl-262 
1-pentyl--D-maltoside. However, purified HpvZ was not obtained due to the lack of 263 
adsorption of the enzyme to a nickel affinity column. Therefore, the enzyme properties 264 
of HpvZ were examined using the membrane fraction prepared from extracts of hpvZ-265 
expressing E. coli cells. 266 
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The optimum pH and temperature for the activity of HpvZ were determined to be 267 
pH 8.5–9.0 and at 40°C–45°C, respectively (Fig. S4). 268 
The substrate range of HpvZ was examined using 200 µM of HPV, HPS, coniferyl 269 
alcohol, sinapyl alcohol, cinnamyl alcohol, 3-(4-hydroxyphenyl)-1-propanol, 270 
homovanillyl alcohol, vanillyl alcohol, GGE, MPHPV, DCA, and DCA-C (Fig. S5). 271 
HPLC analyses of the reaction mixtures indicated that HpvZ showed no activity for a 272 
C6–C2 monomeric alcohol (homovanillyl alcohol), a C6–C1 monomeric alcohol (vanillyl 273 
alcohol), and lignin-derived biaryls, including GGE, MPHPV, and DCA-C (Table 1). On 274 
the other hand, HpvZ showed activities toward all of the C6–C3 monomeric alcohols (3-275 
phenyl-1-propanol derivatives; Table 1). Generally, GMC oxidoreductase family 276 
enzymes act on hydroxyl groups of alcohols, carbohydrates, or sterols (45). For 277 
example, an aryl-alcohol oxidase from Pleurotus eryngii is able to oxidize a variety of 278 
aromatic alcohols and aldehydes, including coniferyl alcohol and cinnamyl alcohol (46). 279 
On the contrary, PhcC and PhcD specifically oxidize the alcohol group at C of the A-280 
ring side chain of DCA-C and DCA, although PhcC has a weak activity for coniferyl 281 
alcohol (40). HpvZ was able to oxidize the alcohol group at C of the B-ring side chain 282 
of DCA, which is different from the regiospecificity of PhcC and PhcD (data not 283 
shown). 284 
Among the enzymes belonging to the GMC oxidoreductase family, an FAD-285 
binding domain (GMC_oxred_N; PF00732) is conserved in the N-terminal region. This 286 
domain includes the typical GxGxxG/A sequence motif, which is indicative of the 287 
Rossmann fold involved in binding the ADP moiety of FAD (47). A substrate-binding 288 
domain is also conserved in the C-terminal region, although this domain is less 289 
conserved. In addition, an active-site histidine, which can assist in substrate oxidation 290 
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and FAD reoxidation by molecular oxygen, is generally conserved (45, 47). These 291 
domains and the residue are also conserved in HpvZ (Fig. S6). To identify the flavin 292 
cofactor in HpvZ, a supernatant obtained by heat treating the membrane fraction 293 
containing HpvZ was analyzed by HPLC. However, a significant peak was not 294 
observed. Furthermore, the specific activities in the presence of FAD (26 ± 8 nmolmin–295 
1mg–1) or flavin mononucleotide (27 ± 1 nmolmin–1mg–1) were almost equivalent to 296 
that in the absence of any flavin cofactors (26 ± 6 nmolmin–1mg–1). GMC 297 
oxidoreductase family enzymes generally contain either covalently or non-covalently 298 
bound FAD (45). Choline oxidase from Arthrobacter globiformis (48) and pyranose 299 
dehydrogenase (AmPDH) from Agaricus meleagris (49) have covalently bound FAD. 300 
Our results suggested that HpvZ may also covalently bind to FAD. Moreover, although 301 
purified inactive HpvZ was obtained from the soluble fraction of the hpvZ-expressing E. 302 
coli cells, UV-visible spectra of the enzyme showed no absorption at 454 nm, indicating 303 
the absence of flavin cofactor in the enzyme (data not shown). This result suggested that 304 
HpvZ produced in the E. coli cytoplasm lacked FAD as a prosthetic group. 305 
 306 
In vivo electron acceptor of HpvZ. AlkJ and PegA are able to use ubiquinone 307 
(CoQ10) and its derivatives (CoQ0 and CoQ1) as electron acceptors for the oxidation of 308 
their substrates (41, 42). PhcC and PhcD have also been shown to be able to use CoQ0 309 
and CoQ1 as electron acceptors as well as PMS (40). Furthermore, electron transport 310 
from AlkJ to cytochrome c in the presence of CoQ1 has been observed (41). Therefore, 311 
the electrons that are removed from the substrate by AlkJ, PegA, and PhcC/PhcD are 312 
thought to be transferred to the respiratory chain. Based on these observations, we 313 
predicted that HpvZ could use ubiquinone as an electron acceptor in the oxidation of 314 
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HPV. When using a membrane fraction of SYK-6 cells harboring pJB12830 (hpvZ-315 
expressing SYK-6), HpvZ showed 1.2- and 1.6-fold higher specific activities in the 316 
presence of CoQ0 (27 ± 2 nmolmin–1mg–1) and CoQ1 (36 ± 6 nmolmin–1mg–1), 317 
respectively, than that in the absence of cofactors (22 ± 1 nmolmin–1mg–1). The 318 
specific activity in the presence of CoQ1 was almost equivalent to that obtained using 319 
PMS (40 ± 3 nmolmin–1mg–1). These results suggested that HpvZ is able to use 320 
ubiquinone as an electron acceptor in vivo. However, no increase in HpvZ activity was 321 
observed when the membrane fraction of hpvZ-expressing E. coli was used. The 322 
difference in the increase in HpvZ activities between the membrane fractions of hpvZ-323 
expressing SYK-6 and E. coli cells in the presence of ubiquinone derivatives may be 324 
caused by a difference in the abundance of ubiquinone in their membrane fractions 325 
employed. 326 
 327 
Identification of the ALDH genes responsible for the conversion of VAL. To 328 
obtain more information on the properties of the enzymes involved in the conversion of 329 
VAL in SYK-6, cofactor requirements of the enzyme activity were examined. Cell 330 
extracts (>10 kDa) of SYK-6 grown in lysogeny broth (LB) were incubated with 200 331 
μM HPV in the presence of FAD, NAD+, and NADP+ for 2 h. In the presence of NAD+ 332 
and NADP+, VAA accumulated to levels of 95 ± 9 µM and 86 ± 6 µM, respectively, 333 
while the accumulation of VAA was not observed in the presence of FAD. These results 334 
suggested that NAD+/NADP+-dependent ALDHs play a major role in VAL oxidation. 335 
Previously, 23 ALDH genes were predicted to be present in the SYK-6 genome 336 
(50, 51). To examine the ability of the putative 23 ALDH gene products to oxidize 337 
VAL, these genes were expressed in E. coli using expression plasmids constructed in a 338 
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previous study (51). SDS-PAGE showed sufficient gene expression except for 339 
SLG_32240 and SLG_34940 (Fig. S7). Since HPV was converted to VAL-Tris during 340 
incubation with HpvZ in Tris-HCl buffer, we employed HEPES buffer (pH 7.5) and 341 
sodium phosphate buffer (pH 7.5) to prepare VAL from HPV using HpvZ. However, 342 
HPV was converted to unknown products in HEPES buffer, and the reaction product 343 
was not detected in sodium phosphate buffer (data not shown). In addition, HPV 344 
conversion rate was significantly decreased in HEPES buffer (approximately 60%) and 345 
sodium phosphate buffer (approximately 50%). Therefore, we examined the ability of 346 
these 21 ALDHs to convert VAL by measuring the amount of VAA produced from 347 
HPV when HPV was reacted with both HpvZ and each ALDH. Resting cells of E. coli 348 
expressing each ALDH gene and hpvZ-expressing E. coli were mixed and incubated 349 
with 100 µM HPV for 12 h. When resting cells of E. coli harboring a vector and the 350 
hpvZ-expressing E. coli were incubated with HPV, VAA was not generated, while VAL-351 
Tris accumulated. On the other hand, when E. coli cells carrying each of the 13 ALDH 352 
genes [SLG_07270, SLG_07610, SLG_07790, SLG_09510, SLG_11410, SLG_12800, 353 
SLG_18210, SLG_20400, SLG_27910 (bzaA), SLG_27920 (bzaB), SLG_28150, 354 
SLG_31150, SLG_38120] were used instead of the control vector, HPV was converted 355 
into VAA (Fig. 5A). Of the 13 ALDH genes, when incubating with E. coli carrying 356 
SLG_07270, SLG_12800, SLG_18210, SLG_20400, bzaA, bzaB, and SLG_31150, 357 
larger amounts of VAA accumulated (Fig. 5A). We, therefore, measured the VAA 358 
production time course using E. coli carrying these 7 ALDH genes and the hpvZ-359 
expressing E. coli. Of these, E. coli carrying SLG_07270, SLG_12800, SLG_20400, 360 
and bzaB produced a greater amount of VAA than E. coli carrying one of the 3 other 361 
ALDH genes (Fig. 5B). Specifically, when using E. coli carrying SLG_20400, the 362 
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amount of VAA produced was the greatest, and no VAL-Tris was detected at any of the 363 
sampling points (Fig. 5B). 364 
In order to examine whether SLG_07270, SLG_12800, SLG_20400, and bzaB are 365 
involved in the conversion of VAL in SYK-6, SLG_07270 mutant (SME092) and 366 
SLG_20400 mutant (SME061) were created (Fig. S3C–F). Resting cells of SME092, 367 
SME061, and the previously created SLG_12800 mutant (SME031) and bzaB mutant 368 
(SME045) were incubated with 1 mM HPV in the presence of hpvZ-expressing E. coli 369 
cells. SME061 accumulated a 1.8-fold greater amount of VAL-Tris than the wild type or 370 
the other mutants after 20 h incubation (Fig. 5C). These results suggested that 371 
SLG_20400 is involved in VAL oxidation. However, SME061 accumulated only 75 µM 372 
VAL-Tris at 20 h of incubation. Therefore, multiple ALDHs including SLG_20400 373 
appear to be involved in the conversion of VAL. Our previous phylogenetic analysis of 374 
the 23 ALDH genes in SYK-6 and other known ALDH genes indicated that 13 SYK-6 375 
ALDH genes, the products of which showed VAL oxidation activities, are 376 
phylogenetically diverse (51). SLG_20400 clustered with calB, which encodes coniferyl 377 
aldehyde dehydrogenase from Pseudomonas sp. strain HR199, which shared 33% 378 
amino acid sequence identity with SLG_20400 (51, 52). Involvement of multiple ALDH 379 
genes in SYK-6 was also shown in the oxidation of vanillin, syringaldehyde, and an 380 
intermediate metabolite of DCA (DCA-L) (50, 51). Another example of the involvement 381 
of multiple ALDH genes in the conversion of vanillin has also been reported for P. 382 
putida KT2440 (53). Since ALDHs exhibit broad substrate ranges in general, multiple 383 
ALDHs are likely to play roles in the oxidation of aromatic aldehydes to their acids. 384 
 385 
Candidate genes for the catabolism of VAA. In a previous report, Palamuru et 386 
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al. detected vanillin as a metabolite when SYK-6 cells were incubated with GGE (24). 387 
However, vanillin was not observed during the conversion of HPV (Fig. 2). In order to 388 
examine whether vanillin is an actual intermediate in HPV catabolism, resting cells of a 389 
desV ligV double mutant (SME077), which has a weak ability to convert vanillin (51), 390 
were incubated with 100 µM VAA or ferulate. Only the accumulation of vanillate and 391 
acetovanillone was observed at any of the sampling points (1, 2, 4, 6, and 24 h) in the 392 
mixture for the VAA conversion, whereas the mixture for the ferulate conversion 393 
accumulated a significant amount of vanillin in addition to vanillate (Fig. 6; 394 
chromatograms at 2 and 4 h of incubation are shown). In addition, when a cell extract 395 
(>10 kDa) of SME077 was incubated with 100 µM VAA in the presence of CoA, 396 
MgSO4, and ATP, only the accumulation of vanillate and acetovanillone was observed 397 
(Fig. S8). These results suggested that VAA was catabolized to vanillate without passing 398 
through vanillin as an intermediate. 399 
We hypothesized that the feruloyl-CoA synthetase gene (ferA) and feruloyl-CoA 400 
hydratase/lyase genes (ferB and ferB2) may be involved in VAA catabolism based on 401 
the structural similarity between VAA and ferulic acid (36). These genes were 402 
adequately expressed in E. coli (Fig. S9). When crude FerA was incubated with 100 µM 403 
VAA in the presence of CoA, MgSO4, and ATP for 60 min, compound IX with a 404 
retention time of 1.7 min was generated (Fig. S10B). Negative ESI-MS analysis of 405 
compound IX showed fragments at m/z 959 ([M - H]-) and 479 ([M - 2H]2-), suggesting 406 
that compound IX was the CoA derivative of VAA (VAA-CoA; Mw, 960) (Fig. S10E). 407 
However, no other peak except VAA-CoA was observed when crude enzymes of FerA + 408 
FerB and FerA + FerB2 were incubated with VAA, respectively (Fig. S10C and D). 409 
Therefore, FerB and FerB2 appear to be not involved in the conversion of VAA-CoA. 410 
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In order to examine whether ferA is indeed involved in the conversion of VAA in 411 
SYK-6, resting cells of a previously created ferA mutant (SME009) grown in LB were 412 
incubated with 100 µM VAA. SME009 showed a higher conversion rate for VAA than 413 
that of the wild type (Fig. S11), suggesting that ferA is not essential for the catabolism 414 
of VAA. The reason for the high conversion rate of VAA of SME009 is not clear but 415 
disruption of ferA may cancel the substrate competition between FerA and (an) 416 
unidentified true VAA-converting enzyme(s). 417 
Recently, the catabolic pathway of p-hydroxycinnamate derivatives, such as 418 
dihydroferulate, ferulate, and p-coumarate in Rhodococcus jostii RHA1, were 419 
characterized (37). In this pathway, dihydroferulate was catabolized to vanillate via 420 
VAA-CoA. VAA-CoA was converted into vanillate and acetyl-CoA by the gene product 421 
of couO (ro0512), which encodes 4-hydroxyphenoxy--ketoacyl-CoA hydrolase. CouO 422 
was predicted to be a zinc-dependent metalloenzyme belonging to amidohydrolase 423 
superfamily. Orthologs of couO, showing 53%–58% amino acid sequence identity, have 424 
also been found and characterized in Agrobacterium fabrum C58 (Atu1421) (38) and 425 
Corynebacterium glutamicum (phdC) (39). In the SYK-6 genome, we found 426 
SLG_12680, which exhibited 50% amino acid sequence identity with CouO. We are 427 
currently investigating the function of the gene product of SLG_12680 and exploring 428 
the actual gene encoding CoA ligase for VAA. 429 
 430 
Genome search for orthologs of hpvZ in other bacteria. Since HpvZ is essential 431 
for the catabolism of HPV and HPS, the presence of this gene determines whether 432 
bacteria can utilize the A-ring portion of -aryl ether compounds. BLAST searches of 433 
hpvZ were carried out to determine the distribution of its orthologs among bacteria. The 434 
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hpvZ orthologs that showed high amino acid sequence identity (62%–92%) were found 435 
in Altererythrobacter sp. strain Root672 (ASD76_15935), Altererythrobacter atlanticus 436 
(WYH_02786), Erythrobacter sp. strain SG61-1L (SZ64_15220), Sphingomonas 437 
hengshuiensis WHSC-8 (TS85_07880), and Sphingobium sp. strain 66-54 438 
(BGP16_16810). All these bacteria possess orthologs of the genes responsible for the 439 
conversion of GGE into HPV. Among these strains, SG61-1L was reported to be able to 440 
utilize GGE as the sole source of carbon and energy (24). By contrast, 441 
Novosphingobium sp. strain MBES04 accumulated HPV from GGE (23). Consistent 442 
with this observation, MBES04 possesses GMC oxidoreductase family enzyme genes, 443 
whose products showed less than 37% amino acid sequence identity with HpvZ. 444 
Similarly, no hpvZ orthologs were found in Novosphingobium sp. strain PP1Y and 445 
Novosphingobium aromaticivorans DSM 12444, which possess orthologs of the genes 446 
responsible for converting GGE into HPV. Due to the lack of hpvZ, PP1Y and DSM 447 
12444 also appear to be able to utilize only the portion of the B-ring of -aryl ether 448 
compounds as carbon and energy sources. 449 
 450 
 451 
MATERIALS AND METHODS 452 
Bacterial strains, plasmids, and culture conditions. The strains and plasmids 453 
used in this study are listed in Table 2. Sphingobium sp. strain SYK-6 and its mutants 454 
were grown in LB, Wx-SEMP, and Wx-SEMP containing 5 mM GGE at 30°C. S. 455 
sanguinis IAM 12578 was grown in LB at 30°C. When necessary, 50 mg 456 
kanamycin/liter, 100 mg streptomycin/liter, or 300 mg carbenicillin/liter were added to 457 
the cultures. E. coli strains were grown in LB at 37°C. For cultures of cells carrying 458 
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antibiotic resistance markers, the media for E. coli transformants were supplemented 459 
with 100 mg ampicillin/liter, 25 mg kanamycin/liter, or 12.5 mg chloramphenicol/liter. 460 
 461 
Synthesis of HPS (S-Hibbert-Westwood-Lancefield ketone; Fig. 7)  462 
Synthesis of 4-((tert-butyldimethylsilyl)oxy)-3,5-dimethoxybenzaldehyde (A) To a 463 
stirring solution of syringaldehyde (20.0 g, 109.8 mmol, 1.0 eq) in dichloromethane 464 
(DCM) (600 ml, c = 0.18 M) was added 4-dimethylaminopyridine (4-DMAP) (13.4 g, 465 
109.8 mmol, 1.0 eq), and imidazole (Imid) (14.9 g, 219.6, 2.0 eq). The resulting mixture 466 
was allowed to stir for 5 min, and then butyldimethylchlorosilane (TBSCl) (17.3 g, 467 
115.3 mmol, 1.1 eq) was added. The mixture was stirred at room temperature for 1 h. 468 
After the reaction had reached completion, it was neutralized with a saturated aqueous 469 
solution of NH4Cl (2  300 ml). The organic layer was further washed with water (500 470 
ml), brine (300 ml), dried with MgSO4, filtered, and concentrated in vacuo. Purification 471 
by silica gel chromatography using 5–10% ethyl acetate (EtOAC) in petroleum ether 472 
afforded compound A as a white solid (26.6 g, 89.8 mmol, 82%). Analytical data for 473 
compound A agreed with that previously reported in the reference (54). 1H NMR (500 474 
MHz, CDCl3) δ 9.79 (s, 1H), 7.07 (s, 2H), 3.84 (s, 6 H), 0.98 (s, 9H), 0.13 (s, 6H); 13C 475 
NMR (125 MHz, CDCl3) δ 191.1, 152.0, 140.7, 129.4, 106.7, 55.8, 25.8, 18.9, -4.46. 476 
Synthesis of Ethyl 3-(4-((tert-butyldimethylsilyl)oxy)-3,5-dimethoxyphenyl)-3-477 
hydroxypropanoate (B) ethyl acetate (4.2 g, 47.5 mmol, 1.3 eq) was added to a cooled 478 
solution of lithium bis(trimethylsilyl)amide (LiHMDS) [1.0 M in tetrahydrofuran 479 
(THF); 47.5 ml, 47.5 mmol, 1.3 eq] in THF (100 ml) at -78°C. After 15 min, a solution 480 
of compound A (10.8 g, 36.6 mmol, 1.0 eq) in THF (20 ml, overall c = 0.30 M) was 481 
added at -78°C and the resulting mixture was left to stir at this temperature for 1 h. After 482 
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the reaction had reached completion, it was quenched with saturated aqueous solution of 483 
NH4Cl (2  300 ml) and extracted with ethyl acetate (500 ml). The organic layer was 484 
further washed with water (500 ml), brine (300 ml), dried with MgSO4, filtered and 485 
concentrated in vacuo. Purification by silica gel chromatography using 10–20% ethyl 486 
acetate in petroleum ether afforded compound B as a light-yellow solid (12.5 g, 32.7 487 
mmol, 89%). 1H NMR (500 MHz, CDCl3) δ 6.51 (s, 2H), 5.00 (dt, J = 9.0, 3.5 Hz, 1H), 488 
4.13 (q, J = 7.0 Hz, 2H), 3.74 (s, 6H), 3.36 (m, 1H), 2.70 (dd, J = 16.0, 9.0 Hz, 1H), 489 
2.63 (dd, J = 16.0, 3.5 Hz, 1H), 1.22 (t, J = 7.0 Hz, 3H), 0.97 (s, 9H), 0.08 (s, 6H); 13C 490 
NMR (125 MHz, CDCl3) δ 172.4, 151.5, 135.2, 133.6, 102.5, 70.6, 60.8, 55.7, 43.7, 491 
25.8, 18.7, 14.2, -4.7. 492 
Synthesis of 1-(4-((tert-butyldimethylsilyl)oxy)-3,5-dimethyoxyphenyl)propane-493 
1,3-diol (C) A suspension of LiAlH4 (1.4 g, 37.8 mmol, 2.2 eq) in THF (100 ml) was 494 
cooled to -20°C. After 15 min, a solution of compound B (6.6 g, 17.2 mmol, 1.0 eq) in 495 
THF (20 ml, overall c = 0.14 M) was added at -20°C and the resulting mixture was left 496 
to stir at this temperature for 1 h. After the reaction had reached completion, it was 497 
poured slowly into a stirring mixture of ethyl acetate (300 ml) and saturated aqueous 498 
solution of Na2S2O3 (2  300 ml). The organic layer was washed brine (300 ml), dried 499 
with MgSO4, filtered and concentrated in vacuo. Purification by silica gel 500 
chromatography using 5–10% methanol in DCM afforded compound C as colorless oil 501 
(5.62 g, 16.4 mmol, 96%). 1H NMR (500 MHz, CDCl3) δ 6.49 (s, 2H), 4.79 (dd, J = 8.5, 502 
3.5 , 1H), 3.77 (m, 2H), 3.75 (s, 6H), 3.32 (s, 1H), 2.93 (s, 1H), 1.94 (dddd, J = 14.0, 503 
8.5, 7.0, 5.0 Hz, 1H), 1.84 (ddt, J = 14.0, 5.5, 4.0 Hz, 1H), 0.98 (s, 9H), 0.09 (s, 6H); 504 
13C NMR (125 MHz, CDCl3) δ 151.6, 137.2, 133.5, 102.6, 74.6, 61.5, 55.8, 40.6, 25.9, 505 
18.8, -4.6. 506 
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Synthesis of 1-(4-((tert-butyldimethylsilyl)oxy)-3,5-dimethyoxyphenyl)-3-507 
hydroxypropan-1-one (D) 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) (4.1 g, 18.1 508 
mmol, 1.05 eq) was added to a stirring solution of compound C (5.6 g, 16.4 mmol, 1.0 509 
eq) in THF (160 ml, c = 0.10 M) at 22°C and the resulting mixture was left to stir at this 510 
temperature for 12 h. Afterwards, the reaction mixture was diluted with ethyl acetate 511 
(300 ml) and washed with saturated aqueous solution of Na2S2O3 (2  300 ml). The 512 
organic layer was washed water (300 ml), brine (300 ml), dried with MgSO4, filtered 513 
and concentrated in vacuo. Purification by silica gel chromatography using 2–5% 514 
methanol in DCM afforded compound D as a white solid (5.1 g, 14.9 mmol, 91%). 1H 515 
NMR (500 MHz, CDCl3) δ 7.16 (s, 2H), 3.97 (app q, J = 5.5 Hz, 2H), 3.80 (s, 6H), 3.15 516 
(t, J = 5.5 Hz, 2H), 3.01 (app t, J = 6.0 Hz, 1H), 0.97 (s, 9H), 0.11 (s, 6H); 13C NMR 517 
(125 MHz, CDCl3) δ 199.1, 151.4, 139.9, 129.4, 105.6, 58.3, 55.8, 40.0, 25.7, 18.8, -518 
4.6. 519 
Synthesis of HPS Tetrabutylammonium fluoride (TBAF) (1.0 M in THF, 8.8 ml, 520 
8.8 mmol, 3.0 eq) was added to a stirring solution of compound D (1.0 g, 2.9 mmol, 1.0 521 
eq) in THF (15 ml, c = 0.20 M) at 22°C and the resulting mixture was left to stir at this 522 
temperature for 1 h. Afterwards, the reaction mixture was diluted with ethyl acetate (300 523 
ml) and washed with saturated aqueous solution of NH4Cl (2  300 ml). The organic 524 
layer was washed water (300 ml), brine (300 ml), dried with MgSO4, filtered and 525 
concentrated in vacuo. The crude material was recrystallized in petroleum ether and 526 
washed with a minimum amount of ethyl acetate to afford compound HPS as a white 527 
solid (0.5 g, 2.3 mmol, 77%). Spectroscopic data agreed with that previously reported in 528 
the reference (30). High-resolution MS [M - H]+ calcd. For C11H13O5 225.0800; found 529 
225.0766; 1H NMR (500 MHz, DMSO-d6) δ 9.34 (s, 1H), 7.24 (s, 2H), 4.59 (s, 1H), 530 
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3.83 (s, 6H), 3.77 (t, J = 6.5 Hz, 2H), 3.10 (t, J = 6.5 Hz, 2H); 13C NMR (125 MHz, 531 
DMSO-d6) δ 197.4, 147.6, 140.8, 127.5, 106.0, 57.3, 56.1, 41.0. 532 
Synthesis of HPV (G-Hibbert-Westwood-Lancefield ketone; Fig. 7)  533 
Synthesis of 4-((tert-butyldimethylsilyl)oxy)-3-methoxybenzaldehyde (E) 534 
Compound E was synthesized following the same experimental procedure as described 535 
for the synthesis of compound A. To vanillin (19.2 g, 126.0 mmol, 1.0 eq) in DCM (500 536 
ml, c = 0.25 M) was added 4-DMAP (15.4 g, 126.0 mmol, 1.0 eq), imidazole (17.1 g, 537 
252.0 mmol, 2.0 eq), and TBSCl (1.2 eq). Purification by silica gel chromatography 538 
using 5–10% ethyl acetate in petroleum ether afforded compound E as colorless oil 539 
(30.0 g, 113.1 mmol, 90%). Spectroscopic data was in agreement with the reference 540 
(55). 1H NMR (400 MHz, CDCl3) δ 9.73 (s, 1H), 7.27 (m, 2H), 6.85 (d, J = 8.0 Hz, 1H), 541 
3.74 (s, 3H), 0.90 (s, 9H), 0.09 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 190.5, 151.4, 542 
151.0, 130.9, 125.8, 120.5, 110.0, 55.1, 25.4, 18.3, -4.78. 543 
Synthesis of Ethyl 3-(4-((tert-butyldimethylsilyl)oxy)-3-methoxyphenyl)-3-544 
hydroxypropanoate (F) Compound F was synthesized following the same experimental 545 
procedure as described for the synthesis of compound B. Compound E (10.9 g, 41.0 546 
mmol, 1.0 eq) in THF (140 ml, c = 0.29 M). LiHMDS (1.0 M in THF; 53.2 ml, 53.2 547 
mmol, 1.3 eq). ethyl acetate (4.7 g, 53.2, 1.3 eq). Purification by silica gel 548 
chromatography using 10–30% ethyl acetate in petroleum ether afforded compound F as 549 
light-yellow oil (11.9 g, 33.6 mmol, 81%). 1H NMR (500 MHz, CDCl3) δ 6.84 (d, J = 550 
1.5 Hz, 1H), 6.72 (m, 2H), 4.98 (dt, J = 5.0, 3.5 Hz, 1H), 4.09 (q, J = 7.0 Hz, 2H), 3.73 551 
(s, 3H), 3.50 (m, 1H), 2.68 (dd, J = 16.0, 9.5 Hz, 1H), 2.59 (dd, J = 16.0, 4.0 Hz, 1H), 552 
1.18 (t, J = 7.0 Hz, 3H), 0.95 (s, 9H), 0.09 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 553 
172.3, 150.9, 144.4, 136.3, 120.6, 118.0, 109.5, 70.2, 60.7, 55.3, 43.6, 25.7, 18.4, 14.1, -554 
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4.7. 555 
Synthesis of 1-(4-((tert-butyldimethylsilyl)oxy)-3-methyoxyphenyl)propane-1,3-556 
diol (G) Compound G was synthesized following the same experimental procedure as 557 
described for the synthesis of compound C. LiAlH4 (1.6 g, 40.1 mmol, 2.2 eq) in THF 558 
(80 ml). Compound F (6.6 g, 18.6 mmol, 1.0 eq) in THF (20 ml, overall c = 0.18 M). 559 
Purification by silica gel chromatography using 5–10% methanol in DCM afforded 560 
compound G as light-yellow oil (5.4 g, 17.4 mmol, 94%). 1H NMR (500 MHz, CDCl3) 561 
δ 6.89 (d, J = 1.5 Hz, 1H), 6.80 (m, 2H), 4.86 (m, 1H), 3.81 (s, 3H), 3.23 (s, 1H), 2.88 562 
(s, 1H), 2.00 (m, 1H), 1.88 (m, 1H), 1.01 (s, 9H), 0.16 (s, 6H); 13C NMR (125 MHz, 563 
CDCl3) δ 151.0, 144.4, 138.1, 120.8, 118.1, 109.6, 74.3, 61.5, 55.6, 40.6, 25.8, 18.6, -564 
4.5. 565 
Synthesis of 1-(4-((tert-butyldimethylsilyl)oxy)-3-methyoxyphenyl)-3-566 
hydroxypropan-1-one (H) Compound H was synthesized following the same 567 
experimental procedure as described for the synthesis of compound D. DDQ (4.3 g, 568 
19.2 mmol, 1.05 eq). Compound G (5.4 g, 17.4 mmol, 1.0 eq) in THF (170 ml, c = 0.10 569 
M). Purification by silica gel chromatography using 2–5% methanol in DCM afforded 570 
compound H as light-yellow oil (4.1 g, 13.3 mmol, 76%). 1H NMR (400 MHz, CDCl3) 571 
δ 7.43-7.35 (m, 2H), 6.82 (d, J = 8.0 Hz, 1H), 3.95 (t, J = 5.5 Hz, 2H), 3.79 (s, 3H), 3.12 572 
(t, J = 5.5 Hz, 2H), 0.94 (s, 9H), 0.13 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 199.1, 573 
151.1, 150.4, 130.8, 122.7, 120.3, 110.9, 58.2, 55.4, 40.0, 25.6, 18.5, -4.6. 574 
Synthesis of HPV HPV was synthesized following the same experimental 575 
procedure as described for the synthesis of HPS. TBAF (1.0 M in THF; 15.6 ml, 15.6 576 
mmol, 1.2 eq). Compound H (4.13 g, 13.3 mmol, 1.0 eq) in THF (100 ml, c = 0.13 M). 577 
Purification by silica gel chromatography afforded HPV as a white solid (1.0 g, 5.1 578 
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mmol, 38%). Spectroscopic analysis was in agreement with the reference (30). High-579 
resolution MS [M + Na]+ calcd. For C10H12O4Na 196.0700; found 219.0625; 
1H NMR 580 
(500 MHz, CDCl3) δ 7.58-7.50 (m, 2H), 6.95 (d, J = 8.0 Hz, 1H), 6.12 (s, 1H), 4.01 (q, 581 
J = 5.0 Hz, 2H), 3.95 (s, 3H), 3.18 (t, J = 5.0 Hz, 2H), 2.73 (app t, J 5.9 = Hz, 1H); 13C 582 
NMR (125 MHz, CDCl3) δ 199.2, 151.0, 146.9, 129.7, 123.8, 114.1, 109.7, 58.5, 56.2, 583 
39.9. 584 
 585 
Preparation of other substrates. MPHPV, DCA, and DCA-C were prepared as 586 
described previously (50, 56). For preparation of VAA, HPV was added into 15 ml of 587 
the cell suspensions of hpvZ-expressing E. coli cells (OD600 of 10.0) and SLG_20400-588 
expressing E. coli cells (OD600 of 2.0) to a final concentration of 200 µM. After 589 
incubation with shaking for 12 h at 30°C, the culture was centrifuged, and the 590 
supernatant was filtered using an Amicon ultra spin filter unit (3-kDa cutoff, Millipore). 591 
The resulting filtrate was used as a preparation of 200 µM VAA. For preparation of 592 
VAL-Tris, HPV was added into 15 ml of the cell suspension of S. sanguinis IAM 12578 593 
harboring pJB12830 cells (OD600 of 1.0) to a final concentration of 1 mM. After 594 
incubation with shaking for 45 h at 30°C, the culture was centrifuged, and the 595 
supernatant was collected. The supernatant was extracted with ethyl acetate, and then 596 
the extract was finally dissolved in the dimethyl sulfoxide. The compounds obtained 597 
were analyzed by HPLC-MS. 598 
Other aromatic compounds were purchased from Tokyo Chemical Ind., Co., Ltd., 599 
Sigma-Aldrich Co., Llc., and Wako Pure Chemical Ind., Ltd. 600 
 601 
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Preparation of resting cells and cell extracts, and fractionation of cell 602 
extracts. Cells of SYK-6 and its mutants grown in Wx-SEMP for 16 h or LB for 24 h 603 
were collected by centrifugation (5,000 × g for 5 min), and then washed twice with 50 604 
mM Tris-HCl buffer (pH 7.5; buffer A). The cells were resuspended in the same buffer 605 
and used as resting cells. Cells were broken by an ultrasonic disintegrator (57), and the 606 
supernatants of cell lysates were obtained as cell extracts after centrifugation (19,000 × 607 
g for 15 min). To examine the cofactor requirements, cell extracts were filtered using an 608 
Amicon ultra spin filter unit (10 kDa cutoff, Millipore) and then washed 5 times with 609 
buffer A. The filtrates were used as cell extracts (>10 kDa). For fractionation of cell 610 
extracts, they were further centrifuged at 124,000 × g for 30 min at 4°C, and the 611 
resulting supernatants were used as the soluble fraction. The pellets were washed twice 612 
with buffer A, resuspended in the same buffer, and used as the membrane fraction. 613 
 614 
Identification of the metabolites. SYK-6 resting cells (OD600 of 5.0) were 615 
incubated with 1 mM HPV or HPS in buffer A at 30°C with shaking. SME077 resting 616 
cells (OD600 of 0.5 or 5.0) were incubated with 100 µM VAA or 1 mM ferulic acid in 617 
buffer A at 30°C with shaking. Following incubation, portions of the reaction mixtures 618 
were collected, and reactions were stopped by centrifugation. Methanol was added to 619 
the resulting supernatants (final concentration, 40%), and the filtrated samples were 620 
analyzed by HPLC-MS. 621 
SYK-6 cell extracts (>10 kDa; 500 µg protein/ml) were incubated with 200 µM 622 
HPV or HPS in the presence and absence of 500 µM NAD+ or 500 µM NAD+ + 2 mM 623 
CoA + 2.5 mM MgSO4 + 2.5 mM ATP in buffer A at 30°C. SME077 cell extracts (>10 624 
kDa; 500 µg protein/ml) were incubated with 100 µM VAA in the presence of 1 mM 625 
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CoA + 1.25 mM MgSO4 + 1.25 mM ATP in buffer A at 30°C. The reactions were 626 
stopped by the addition of methanol or acetonitrile (final concentration, 50%) at various 627 
sampling time points. Precipitated proteins were removed by centrifugation at 19,000 × 628 
g for 15 min. The resulting supernatants of the reaction mixtures were analyzed by 629 
HPLC-MS. 630 
 631 
Enzyme assays using cell extracts of SYK-6. HPV-oxidizing activities of SYK-632 
6 cell extracts were determined by measuring the decrease in the amount of HPV by 633 
HPLC analysis. In order to examine the effect of GGE on enzyme induction, SYK-6 634 
cells grown in LB were inoculated into Wx-SEMP to an OD600 of 0.2, and grown at 635 
30°C. GGE (5 mM) was added when the OD600 of the culture reached 0.5, and the 636 
culture was then further incubated for 12 h. SYK-6 cell extracts (500 µg protein/ml) 637 
were incubated with 200 µM HPV in the presence and absence of cofactors (500 µM 638 
PMS, 500 µM FAD + PMS, or 500 µM NAD+) in buffer A for 30 min at 30°C. The 639 
reaction mixtures were analyzed by HPLC, and HPV was detected at 276 nm. The 640 
specific activity was expressed in moles of HPV converted per min per milligram of 641 
protein. 642 
In order to examine the activity of VAL-oxidizing activity, production of VAA 643 
from HPV was measured when HPV was reacted with SYK-6 cell extracts (>10 kDa). 644 
The cell extracts (>10 kDa; 500 µg protein/ml) were incubated with HPV in the 645 
presence of cofactors (500 µM FAD, 500 µM NAD+, or 500 µM NADP+) in buffer A 646 
for 2 h at 30°C. The supernatant of the reaction mixtures was analyzed by HPLC, and 647 
compounds were detected at 280 nm. 648 
 649 
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Analytical methods. HPLC-MS analysis was performed with the ACQUITY 650 
UPLC system (Waters) coupled with an ACQUITY TQ detector as described previously 651 
(58). Reaction products of HPV, coniferyl alcohol, sinapyl alcohol, cinnamyl alcohol, 3-652 
(4-hydroxyphenyl)-1-propanol, homovanillyl alcohol, vanillyl alcohol, GGE, MPHPV, 653 
DCA, and DCA-C were analyzed using TSKgel ODS-140HTP column (2.1 × 100 mm; 654 
Tosoh). Reaction products of HPS were analyzed using ACQUITY UPLC BEH C18 655 
column (2.1 × 100 mm; Waters). Reaction products of VAA was analyzed using both 656 
columns. All analyses were carried out at a flow rate of 0.5 ml/min. The mobile phase 657 
was a mixture of solution A (acetonitrile containing 0.1% formate) and B (water 658 
containing 0.1% formate) with the following conditions: Detection of the reaction 659 
products of HPV: 0–4.2 min, 5% A; 4.2–6.0 min, linear gradient from 5% to 30% A; 6.0–660 
6.5 min, decreasing gradient from 30% to 5% A; 6.5–7.0 min, 5% A. Detection of VAL 661 
generated from HPV: 0–4.7 min, 5% A; 4.7–4.9 min, linear gradient from 5% to 80%; 662 
4.9–7.0 min, 80% A. Detection of VAA-CoA generated from VAA: 0–0.8 min, 10% A; 0.8–663 
1.0 min, linear gradient from 10% to 25% A; 1.0–1.5 min, 25% A; 1.5–1.8 min, 664 
decreasing gradient from 25% to 10% A; 1.8-3.0 min, 10% A. Detection of vanillate 665 
generated from VAA: 0–3.0 min, linear gradient from 5% to 15% A; 3.0–4.0 min, 666 
decreasing gradient from 15% to 5%. Detection of the reaction product of vanillyl 667 
alcohol: 0–5.0 min, 5% A. Detection of the reaction products of coniferyl alcohol, sinapyl 668 
alcohol, cinnamyl alcohol, homovanillyl alcohol, and HPS: 0–7.0 min, 10% A. Detection 669 
of the reaction products of 3-(4-hydroxyphenyl)-1-propanol, GGE, and ferulate: 0–5.0 670 
min, 15% A. Detection of the reaction products of MPHPV, DCA, and DCA-C: 0–5.0 min, 671 
25% A. HPV, HPS, VAL, VAL-Tris, VAA, VAA-CoA, vanillate, syringate, acetovanillone, 672 
coniferyl alcohol, sinapyl alcohol, cinnamyl alcohol, 3-(4-hydroxyphenyl)-1-propanol, 673 
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homovanillyl alcohol, vanillyl alcohol, GGE, MPHPV, DCA, and DCA-C were detected 674 
at 276, 300, 310, 352, 280, 300, 260, 276, 275, 263, 273, 250, 276, 279, 279, 277, 280, 675 
277, and 326 nm, respectively. In ESI-MS analysis, MS spectra were obtained using the 676 
positive- and negative-ion modes with the settings described in our previous study (58). 677 
Protein concentrations were determined by the Bradford method using the Bio-Rad 678 
protein assay kit or by Lowry’s assay using the DC protein assay kit (Bio-Rad 679 
Laboratories). The expression of the genes was analyzed by SDS-PAGE. Protein bands 680 
in gels were stained with Coomassie Brilliant Blue. 681 
 682 
DNA manipulations and sequence analysis. PCR primers used in this study are 683 
listed in Table 3. Nucleotide sequences were determined using a CEQ 2000XL genetic 684 
analysis system (Beckman Coulter). Sequence analysis was performed with the 685 
MacVector program (MacVector, Inc.). Sequence similarity searches, pairwise 686 
alignments, and multiple alignments were carried out using the BLASTP program (59), 687 
the EMBOSS Needle program through the EMBL-EBI server (60), and the Clustal 688 
Omega program (61), respectively. 689 
 690 
Cloning of hpvZ. A partially SalI-digested gene library of SYK-6 constructed 691 
with pVK100 was introduced into a host strain, S. sanguinis IAM 12578, by triparental 692 
mating (62). The ability of 1000 transconjugants grown in diluted LB to transform 15 693 
µM HPV was analyzed by HPLC. Southern hybridization analysis of the SalI digests of 694 
positive clones with pSA53 as a probe was carried out using the digoxigenin (DIG) 695 
system (Roche Diagnostics). The hybridized SalI fragments were cloned in pBluescript 696 
II SK(+), and the nucleotide sequences of both ends of the inserts were determined. 697 
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 698 
Expression of SYK-6 genes in E. coli and SYK-6. A DNA fragment carrying 699 
hpvZ was amplified by PCR using SYK-6 total DNA as a template. The amplified 700 
fragment was ligated into pT7Blue, and the NdeI-BamHI fragment of the resulting 701 
plasmid was then inserted in pCold I to generate pCold12830. DNA fragments carrying 702 
ferB and ferB2 were amplified by PCR. The amplified fragments were ligated into pET-703 
16b to obtain pE16FB and pE16FB2. Nucleotide sequences of their inserts were 704 
confirmed by nucleotide sequencing. Expression plasmids for SYK-6 ALDH genes and 705 
ferA were prepared in previous studies (31, 51). The expression plasmids were 706 
introduced into E. coli BL21(DE3), and the transformed cells were grown in LB. In the 707 
case of hpvZ expression, pTf16 encoding the trigger factor chaperone was introduced 708 
into E. coli BL21(DE3) in addition to pCold12830, and the resulting transformant was 709 
grown in the presence of 0.5 mg/ml L-arabinose. Expression of hpvZ and other genes 710 
were induced for 24 h at 16°C and for 4 h at 30°C, respectively, by adding 0.1–1 mM 711 
isopropyl--D-thiogalactopyranoside when the OD600 of the cultures reached 0.5. Cells 712 
were then harvested by centrifugation and washed with buffer A. pJB12830 was created 713 
by inserting the 2.3-kb BamHI-SacII (blunted) fragment carrying hpvZ from pBH37F 714 
into pJB864. pJB12830 was introduced into SYK-6, and the transformed cells were 715 
grown in LB containing 1 mM m-toluate for 24 h. Resting cells and cell extracts were 716 
prepared as described above. 717 
 718 
Construction of mutants. To construct pKmb12830K, the 1.3-kb SalI-BamHI 719 
fragment carrying the kanamycin resistance gene (kan) of pIK03 was inserted into the 720 
XhoI-BglII sites in hpvZ of pUC12830. The 3.1-kb SalI fragment of the resulting 721 
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plasmid was ligated into the same site of pK19mobsacB to obtain pKmb12830K. To 722 
construct pKmb07270K, the 1.5-kb HindIII-XbaI fragment of pKS0727 was ligated into 723 
the same sites of pK18mobsacB, yielding pKmb07270. pKmb07270K was constructed 724 
by inserting kan into the NruI site in SLG_07270 of pKmb07270. pKmb12830K and 725 
pKmb07270K were independently introduced into SYK-6 cells by electroporation, and 726 
candidate mutants were isolated as described previously (63). Disruption of each gene 727 
was examined by Southern hybridization analysis (Fig. S3). To construct pAK20400, 728 
upstream and downstream regions (ca. 1.0 kb each) of SLG_20400 were amplified by 729 
PCR. The resulting fragments were cloned into pAK405 by In-fusion cloning (In-Fusion 730 
HD Cloning Kit; Takara Bio). pAK20400 was introduced into SYK-6 cells by 731 
triparental mating (62), and the mutant strain was selected as described previously (64). 732 
Disruption of the gene was confirmed by colony PCR. For the complementation of hpvZ 733 
in SME059, pJB12830 was introduced into cells by electroporation. 734 
 735 
Resting cell assays. Resting cells of E. coli harboring pCold12830 and pTf16 736 
(OD600 of 10.0), SYK-6 (OD600 of 0.5, 1.0, or 5.0), SYK-6 harboring pJB864 (OD600 of 737 
1.0), SME059 (OD600 of 0.5, 1.0, or 5.0), SME059 harboring pJB864 (OD600 of 1.0), 738 
SME059 harboring pJB12830 (OD600 of 1.0), and SME009 (OD600 of 1.0) prepared 739 
from LB-grown cultures were incubated with substrates (200 µM HPV, 200 µM HPS, 740 
200 µM GGE, or 100 µM VAA) at 30°C with shaking. Portions of the cultures were 741 
collected and the amounts of substrates were measured by HPLC. 742 
 743 
Enzyme properties of HpvZ. To determine the cellular localization of HpvZ, the 744 
HPV-oxidizing activities of the soluble and membrane fractions prepared from cell 745 
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extracts of SYK-6 were measured. The cell extracts (500 µg of protein/ml), soluble 746 
fraction (500 µg mg of protein/ml), and membrane fraction (500 µg of protein/ml) were 747 
incubated with 200 µM HPV and 500 µM PMS in buffer A for 10 or 30 min at 30°C. 748 
The amounts of HPV were measured by HPLC. 749 
The enzyme reaction was typically carried out by incubating the membrane 750 
fraction (300 µg of protein/ml) of E. coli cells harboring pCold12830 and pTf16 with 751 
200 µM HPV and 500 µM PMS in buffer A for 10 min at 30°C. Following incubation, 752 
the amount of substrate was measured by HPLC. The optimum pH was determined at 753 
pH ranges from 7.0 to 10.0 using 50 mM GTA buffer (50 mM 3,3-dimethylglutaric acid, 754 
50 mM Tris, and 50 mM 2-amino-2-methyl-1,3-propanediol; pH 7.0 to 9.0) and 50 mM 755 
CHES (N-cyclohexyl-2-aminoethanesulfonic acid) buffer (pH 8.6 to 10) at 30°C. The 756 
optimum temperature was determined at temperature ranges from 25°C to 50°C using 757 
buffer A. To determine the substrate range, 200 µM of HPV, HPS, coniferyl alcohol, 758 
sinapyl alcohol, cinnamyl alcohol, 3-(4-hydroxyphenyl)-1-propanol, homovanillyl 759 
alcohol, vanillyl alcohol, GGE, MPHPV, DCA, and DCA-C were used for the reaction, 760 
and the decrease in the amount of substrate was measured by HPLC. To examine the 761 
effect of flavin cofactors on HpvZ activity, the activities of HpvZ in the presence of 500 762 
µM FAD or flavin mononucleotide were determined. To examine the effect of 763 
ubiquinone derivatives on HpvZ activity, the activities of HpvZ in the presence of CoQ0 764 
and CoQ1 were determined. The enzyme reactions were carried out by incubating 765 
membrane fractions of E. coli cells harboring pCold12830 and pTf16 (300 µg of 766 
protein/ml) or SYK-6 cells harboring pJB12830 (300 µg of protein/ml) with 200 µM 767 
HPV and 500 µM CoQ0 or CoQ1 in buffer A for 10 and 5 min, respectively, at 30°C. 768 
The decrease in the substrate was determined by HPLC analysis. 769 
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 770 
Identification of the ALDH genes involved in VAL conversion. The abilities of 771 
the 23 ALDHs of SYK-6 to convert VAL were examined by measuring the amount of 772 
VAA produced from HPV when HPV was reacted with both HpvZ and each ALDH. 773 
Resting cells of E. coli expressing each ALDH gene (OD600 of 1.0) and E. coli 774 
harboring pCold12830 and pTf16 (OD600 of 5.0 or 10.0) were incubated with 100 µM 775 
HPV in buffer A at 30°C with shaking. Portions of the cultures were collected at various 776 
sampling time points, and the supernatants of the reaction mixtures were analyzed by 777 
HPLC. 778 
The mixtures of resting cells of SYK-6, SME031, SME045, SME061, or SME092 779 
(OD600 of 0.5) and resting cells of E. coli harboring pCold12830 and pTf16 (OD600 of 780 
10.0) were incubated with 1 mM HPV in buffer A at 30°C with shaking. Portions of the 781 
reaction mixtures were collected at various sampling time points. The supernatants 782 
prepared were analyzed by HPLC. 783 
 784 
Conversion of VAA by enzymes for ferulate catabolism. Crude enzymes of 785 
FerA, FerB, and FerB2 were prepared from the E. coli transformants described above. 786 
FerA, FerA + FerB, and FerA + FerB2 (100 µg protein/ml of each) were incubated with 787 
100 µM VAA, 1 mM CoA, 1.25 mM MgSO4, and 1.25 mM ATP in buffer A for 60 min 788 
at 30°C. The supernatants prepared were analyzed by HPLC. 789 
 790 
 791 
ACKNOWLEDGMENTS 792 
 35 
We thank Daisuke Sato for assistance with the construction of mutants. We would also 793 
like to thank Daniel Miles-Barrett and Amol Thakkar for their contributions. This work 794 
was supported in part by a grant from the JSPS KAKENHI Grant Number 26850046, 795 
and the Japan Science and Technology Agency (Advanced Low Carbon Technology 796 
Research and Development Program). 797 
 36 
REFERENCES 798 
1. Boerjan W, Ralph J, Baucher M. 2003. Lignin biosynthesis. Annu Rev Plant 799 
Biol 54:519-546. 800 
2. Ralph J, Lundquist K, Brunow G, Lu F, Kim H, Schatz PF, Marita JM, 801 
Hatfield RD, Ralph SA, Christensen JH, Boerjan W. 2004. Lignins: natural 802 
polymers from oxidative coupling of 4-hydroxyphenyl-propanoids. Phytochem 803 
Rev 3:29-60. 804 
3. Doherty WOS, Mousavioun P, Fellows CM. 2011. Value-adding to cellulosic 805 
ethanol: Lignin polymers. Ind Crop prod 33:259-276. 806 
4. Zakzeski J, Bruijnincx PCA, Jongerius AL, Weckhuysen BM. 2010. The 807 
catalytic valorization of lignin for the production of renewable chemicals. Chem 808 
Rev 110:3552-3599. 809 
5. Otsuka Y, Nakamura M, Shigehara K, Sugimura K, Masai E, Ohara S, 810 
Katayama Y. 2006. Efficient production of 2-pyrone 4,6-dicarboxylic acid as a 811 
novel polymer-based material from protocatechuate by microbial function. Appl 812 
Microbiol Biotechnol 71:608-614. 813 
6. Michinobu T, Bito M, Yamada Y, Tanimura M, Katayama Y, Masai E, 814 
Nakamura M, Otsuka Y, Ohara S, Shigehara K. 2009. Fusible, elastic, and 815 
biodegradable polyesters of 2-pyrone-4,6-dicarboxylic acid (PDC). Polym J 816 
41:1111-1116. 817 
7. Michinobu T, Hiraki K, Inazawa Y, Katayama Y, Masai E, Nakamura M, 818 
Ohara S, Shigehara K. 2011. Click synthesis and adhesive properties of novel 819 
biomass-based polymers from lignin-derived stable metabolic intermediate. 820 
Polym J 43:648-653. 821 
8. Sonoki T, Morooka M, Sakamoto K, Otsuka Y, Nakamura M, Jellison J, 822 
Goodell B. 2014. Enhancement of protocatechuate decarboxylase activity for the 823 
effective production of muconate from lignin-related aromatic compounds. J 824 
Biotechnol 192 Pt A:71-77. 825 
9. Johnson CW, Salvachúa D, Khanna P, Smith H, Peterson DJ, Beckham GT. 826 
2016. Enhancing muconic acid production from glucose and lignin-derived 827 
aromatic compounds via increased protocatechuate decarboxylase activity. Metab 828 
Eng Commun 3:111-119. 829 
10. Sonoki T, Takahashi K, Sugita H, Hatamura M, Azuma Y, Sato T, Suzuki S, 830 
Kamimura N, Masai E. 2018. Glucose-free cis, cis-muconic acid production via 831 
new metabolic designs corresponding to the heterogeneity of lignin. ACS 832 
Sustainable Chem Eng 6:1256-1264. 833 
 37 
11. Linger JG, Vardon DR, Guarnieri MT, Karp EM, Hunsinger GB, Franden 834 
MA, Johnson CW, Chupka G, Strathmann TJ, Pienkos PT, Beckham GT. 835 
2014. Lignin valorization through integrated biological funneling and chemical 836 
catalysis. Proc Natl Acad Sci U S A 111:12013-12018. 837 
12. Akiyama T, Magara K, Matsumoto Y, Meshitsuka G, Ishizu A, Lundquist K. 838 
2000. Proof of the presence of racemic forms of arylglycerol-β-aryl ether structure 839 
in lignin: studies on the stereo structure of lignin by ozonation. J Wood Sci 840 
46:414-415. 841 
13. Kamimura N, Takahashi K, Mori K, Araki T, Fujita M, Higuchi Y, Masai E. 842 
2017. Bacterial catabolism of lignin‐derived aromatics: New findings in a recent 843 
decade: Update on bacterial lignin catabolism. Environ Microbiol Rep 9:679-705. 844 
14. Sato Y, Moriuchi H, Hishiyama S, Otsuka Y, Oshima K, Kasai D, Nakamura 845 
M, Ohara S, Katayama Y, Fukuda M, Masai E. 2009. Identification of three 846 
alcohol dehydrogenase genes involved in the stereospecific catabolism of 847 
arylglycerol-β-aryl ether by Sphingobium sp. strain SYK-6. Appl Environ 848 
Microbiol 75:5195-5201. 849 
15. Masai E, Ichimura A, Sato Y, Miyauchi K, Katayama Y, Fukuda M. 2003. 850 
Roles of the enantioselective glutathione S-transferases in cleavage of β-aryl ether. 851 
J Bacteriol 185:1768-1775. 852 
16. Tanamura K, Abe T, Kamimura N, Kasai D, Hishiyama S, Otsuka Y, 853 
Nakamura M, Kajita S, Katayama Y, Fukuda M, Masai E. 2011. 854 
Characterization of the third glutathione S-transferase gene involved in 855 
enantioselective cleavage of the β-aryl ether by Sphingobium sp. strain SYK-6. 856 
Biosci Biotechnol Biochem 75:2404-2407. 857 
17. Meux E, Prosper P, Masai E, Mulliert G, Dumarçay S, Morel M, Didierjean 858 
C, Gelhaye E, Favier F. 2012. Sphingobium sp. SYK-6 LigG involved in lignin 859 
degradation is structurally and biochemically related to the glutathione transferase 860 
omega class. FEBS Lett 586:3944-3950. 861 
18. Pereira JH, Heins RA, Gall DL, McAndrew RP, Deng K, Holland KC, 862 
Donohue TJ, Noguera DR, Simmons BA, Sale KL, Ralph J, Adams PD. 2016. 863 
Structural and biochemical characterization of the early and late enzymes in the 864 
lignin β-aryl ether cleavage pathway from Sphingobium sp. SYK-6. J Biol Chem 865 
291:10228-10238. 866 
19. Reiter J, Strittmatter H, Wiemann LO, Schieder D, Sieber V. 2013. Enzymatic 867 
cleavage of lignin β-O-4 aryl ether bonds via net internal hydrogen transfer. Green 868 
Chem 15:1373-1381. 869 
 38 
20. Gall DL, Kim H, Lu F, Donohue TJ, Noguera DR, Ralph J. 2014. 870 
Stereochemical features of glutathione-dependent enzymes in the Sphingobium sp. 871 
strain SYK-6 β-aryl etherase pathway. J Biol Chem 289:8656-8667. 872 
21. Gall DL, Ralph J, Donohue TJ, Noguera DR. 2014. A group of sequence-873 
related sphingomonad enzymes catalyzes cleavage of β-aryl ether linkages in 874 
lignin β-guaiacyl and β-syringyl ether dimers. Environ Sci Technol 48:12454-875 
12463. 876 
22. Picart P, Müller C, Mottweiler J, Wiermans L, Bolm C, Domínguez de María 877 
P, Schallmey A. 2014. From gene towards selective biomass valorization: 878 
bacterial β-etherases with catalytic activity on lignin-like polymers. 879 
ChemSusChem 7:3164-3171. 880 
23. Ohta Y, Nishi S, Hasegawa R, Hatada Y. 2015. Combination of six enzymes of 881 
a marine Novosphingobium converts the stereoisomers of β-O-4 lignin model 882 
dimers into the respective monomers. Sci Rep 5:15105. 883 
24. Palamuru S, Dellas N, Pearce SL, Warden AC, Oakeshott JG, Pandey G. 884 
2015. Phylogenetic and kinetic characterization of a suite of dehydrogenases from 885 
a newly isolated bacterium, strain SG61-1L, that catalyze the turnover of 886 
guaiacylglycerol-β-guaiacyl ether stereoisomers. Appl Environ Microbiol 887 
81:8164-8176. 888 
25. Picart P, Sevenich M, P DdM, Schallmey A. 2015. Exploring glutathione lyases 889 
as biocatalysts: paving the way for enzymatic lignin depolymerization and future 890 
stereoselective applications. Green Chem 17:4931-4940. 891 
26. Helmich KE, Pereira JH, Gall DL, Heins RA, McAndrew RP, Bingman C, 892 
Deng K, Holland KC, Noguera DR, Simmons BA, Sale KL, Ralph J, Donohue 893 
TJ, Adams PD, Phillips GN, Jr. 2016. Structural basis of stereospecificity in the 894 
bacterial enzymatic cleavage of β-aryl ether bonds in lignin. J Biol Chem 895 
291:5234-5246. 896 
27. Ohta Y, Hasegawa R, Kurosawa K, Maeda AH, Koizumi T, Nishimura H, 897 
Okada H, Qu C, Saito K, Watanabe T, Hatada Y. 2017. Enzymatic specific 898 
production and chemical functionalization of phenylpropanone platform 899 
monomers from lignin. ChemSusChem 10:425-433. 900 
28. Rosini E, Allegretti C, Melis R, Cerioli L, Conti G, Pollegioni L, D'Arrigo P. 901 
2016. Cascade enzymatic cleavage of the β-O-4 linkage in a lignin model 902 
compound. Catal Sci Technol 6:2195-2205. 903 
29. Higuchi Y, Takahashi K, Kamimura N, Masai E. 2018. Bacterial enzymes for 904 
the cleavage of lignin β-aryl ether bonds: properties and applications. In Beckham 905 
 39 
GT (ed), Lignin Valorization: Emerging Approaches. The Royal Society of 906 
Chemistry (in press). 907 
30. Lancefield CS, Ojo OS, Tran F, Westwood NJ. 2015. Isolation of functionalized 908 
phenolic monomers through selective oxidation and C-O bond cleavage of the β‐909 
O‐4 linkages in lignin. Angew Chem Int Ed Engl 54:258-262. 910 
31. Kasai D, Kamimura N, Tani K, Umeda S, Abe T, Fukuda M, Masai E. 2012. 911 
Characterization of FerC, a MarR-type transcriptional regulator, involved in 912 
transcriptional regulation of the ferulate catabolic operon in Sphingobium sp. 913 
strain SYK-6. FEMS Microbiol Lett 332:68-75. 914 
32. Bubb WA, Berthon HA, Kuchel PW. 1995. Tris buffer reactivity with low-915 
molecular-weight aldehydes - NMR characterization of the reactions of 916 
glyceraldehyde-3-phosphate. Bioorg Chem 23:119-130. 917 
33. Fukuzumi T, Oyake S, Matsumoto H. 1974. Synthesis of vanilloyl acetaldehyde. 918 
Mokuzai Gakkaishi 20:138-142. 919 
34. Niwa M, Saburi Y. 2002. Vanilloyl acetic acid as an unstable intermediate from 920 
β-hydroxypropiovanillone to acetovanillone. Holzforschung 56:360-362. 921 
35. Overhage J, Priefert H, Steinbüchel A. 1999. Biochemical and genetic analyses 922 
of ferulic acid catabolism in Pseudomonas sp. strain HR199. Appl Environ 923 
Microbiol 65:4837-4847. 924 
36. Masai E, Harada K, Peng X, Kitayama H, Katayama Y, Fukuda M. 2002. 925 
Cloning and characterization of the ferulic acid catabolic genes of Sphingomonas 926 
paucimobilis SYK-6. Appl Environ Microbiol 68:4416-4424. 927 
37. Otani H, Lee YE, Casabon I, Eltis LD. 2014. Characterization of p-928 
hydroxycinnamate catabolism in a soil Actinobacterium. J Bacteriol 196:4293-929 
4303. 930 
38. Campillo T, Renoud S, Kerzaon I, Vial L, Baude J, Gaillard V, Bellvert F, 931 
Chamignon C, Comte G, Nesme X, Lavire C, Hommais F. 2014. Analysis of 932 
hydroxycinnamic acid degradation in Agrobacterium fabrum reveals a coenzyme 933 
A-dependent, beta-oxidative deacetylation pathway. Appl Environ Microbiol 934 
80:3341-3349. 935 
39. Kallscheuer N, Vogt M, Kappelmann J, Krumbach K, Noack S, Bott M, 936 
Marienhagen J. 2016. Identification of the phd gene cluster responsible for 937 
phenylpropanoid utilization in Corynebacterium glutamicum. Appl Microbiol 938 
Biotechnol 100:1871-1881. 939 
40. Takahashi K, Hirose Y, Kamimura N, Hishiyama S, Hara H, Araki T, Kasai 940 
D, Kajita S, Katayama Y, Fukuda M, Masai E. 2015. Membrane-associated 941 
 40 
glucose-methanol-choline oxidoreductase family enzymes PhcC and PhcD are 942 
essential for enantioselective catabolism of dehydrodiconiferyl alcohol. Appl 943 
Environ Microbiol 81:8022-8036. 944 
41. Kirmair L, Skerra A. 2014. Biochemical analysis of recombinant AlkJ from 945 
Pseudomonas putida reveals a membrane-associated, flavin adenine dinucleotide-946 
dependent dehydrogenase suitable for the biosynthetic production of aliphatic 947 
aldehydes. Appl Environ Microbiol 80:2468-2477. 948 
42. Ohta T, Kawabata T, Nishikawa K, Tani A, Kimbara K, Kawai F. 2006. 949 
Analysis of amino acid residues involved in catalysis of polyethylene glycol 950 
dehydrogenase from Sphingopyxis terrae, using three-dimensional molecular 951 
modeling-based kinetic characterization of mutants. Appl Environ Microbiol 952 
72:4388-4396. 953 
43. Kawai F, Kimura T, Fukaya M, Tani Y, Ogata K, Ueno T, Fukami H. 1978. 954 
Bacterial oxidation of polyethylene glycol. Appl Environ Microbiol 35:679-684. 955 
44. Matsushita K, Ameyama M. 1982. D-glucose dehydrogenase from 956 
Pseudomonas fluorescens, membrane-bound. Methods Enzymol 89:149-154. 957 
45. Romero E, Gadda G. 2014. Alcohol oxidation by flavoenzymes. Biomol 958 
Concepts 5:299-318. 959 
46. Guillén F, Martínez AT, Martínez MJ. 1992. Substrate specificity and 960 
properties of the aryl-alcohol oxidase from the ligninolytic fungus Pleurotus 961 
eryngii. Eur J Biochem 209:603-611. 962 
47. Dijkman WP, de Gonzalo G, Mattevi A, Fraaije MW. 2013. Flavoprotein 963 
oxidases: classification and applications. Appl Microbiol Biotechnol 97:5177-964 
5188. 965 
48. Quaye O, Lountos GT, Fan F, Orville AM, Gadda G. 2008. Role of Glu312 in 966 
binding and positioning of the substrate for the hydride transfer reaction in choline 967 
oxidase. Biochemistry 47:243-256. 968 
49. Tan TC, Spadiut O, Wongnate T, Sucharitakul J, Krondorfer I, Sygmund C, 969 
Haltrich D, Chaiyen P, Peterbauer CK, Divne C. 2013. The 1.6 Å crystal 970 
structure of pyranose dehydrogenase from Agaricus meleagris rationalizes 971 
substrate specificity and reveals a flavin intermediate. PLoS One 8:e53567. 972 
50. Takahashi K, Kamimura N, Hishiyama S, Hara H, Kasai D, Katayama Y, 973 
Fukuda M, Kajita S, Masai E. 2014. Characterization of the catabolic pathway 974 
for a phenylcoumaran-type lignin-derived biaryl in Sphingobium sp. strain SYK-975 
6. Biodegradation 25:735-745. 976 
51. Kamimura N, Goto T, Takahashi K, Kasai D, Otsuka Y, Nakamura M, 977 
 41 
Katayama Y, Fukuda M, Masai E. 2017. A bacterial aromatic aldehyde 978 
dehydrogenase critical for the efficient catabolism of syringaldehyde. Sci Rep 979 
7:44422. 980 
52. Achterholt S, Priefert H, Steinbüchel A. 1998. Purification and characterization 981 
of the coniferyl aldehyde dehydrogenase from Pseudomonas sp. strain HR199 and 982 
molecular characterization of the gene. J Bacteriol 180:4387-4391. 983 
53. Simon O, Klaiber I, Huber A, Pfannstiel J. 2014. Comprehensive proteome 984 
analysis of the response of Pseudomonas putida KT2440 to the flavor compound 985 
vanillin. J Proteomics 109:212-227. 986 
54. Cushman M, Nagarathnam D, Gopal D, He HM, Lin CM, Hamel E. 1992. 987 
Synthesis and evaluation of analogues of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-988 
trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents. J Med 989 
Chem 35:2293-2306. 990 
55. Shirai T, Kumihashi K, Sakasai M, Kusuoku H, Shibuya Y, Ohuchi A. 2017. 991 
Identification of a novel TRPM8 agonist from nutmeg: a promising cooling 992 
compound. ACS Med Chem Lett 8:715-719. 993 
56. Hishiyama S, Otsuka Y, Nakamura M, Ohara S, Kajita S, Masai E, 994 
Katayama Y. 2012. Convenient synthesis of chiral lignin model compounds via 995 
optical resolution: four stereoisomers of guaiacylglycerol-β-guaiacyl ether and 996 
both enantiomers of 3-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-2-(2-997 
methoxyphenoxy)-propan-1-one (erone). Tetrahedron Lett 53:842-845. 998 
57. Fukuhara Y, Kamimura N, Nakajima M, Hishiyama S, Hara H, Kasai D, 999 
Tsuji Y, Narita-Yamada S, Nakamura S, Katano Y, Fujita N, Katayama Y, 1000 
Fukuda M, Kajita S, Masai E. 2013. Discovery of pinoresinol reductase genes 1001 
in sphingomonads. Enzyme Microb Technol 52:38-43. 1002 
58. Fukuhara Y, Inakazu K, Kodama N, Kamimura N, Kasai D, Katayama Y, 1003 
Fukuda M, Masai E. 2010. Characterization of the isophthalate degradation 1004 
genes of Comamonas sp. strain E6. Appl Environ Microbiol 76:519-527. 1005 
59. Johnson M, Zaretskaya I, Raytselis Y, Merezhuk Y, McGinnis S, Madden TL. 1006 
2008. NCBI BLAST: a better web interface. Nucleic Acids Res 36:W5-9. 1007 
60. Li W, Cowley A, Uludag M, Gur T, McWilliam H, Squizzato S, Park YM, 1008 
Buso N, Lopez R. 2015. The EMBL-EBI bioinformatics web and programmatic 1009 
tools framework. Nucleic Acids Res 43:W580-584. 1010 
61. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, 1011 
McWilliam H, Remmert M, Söding J, Thompson JD, Higgins DG. 2011. Fast, 1012 
scalable generation of high‐quality protein multiple sequence alignments using 1013 
 42 
Clustal Omega. Mol Syst Biol 7:539. 1014 
62. Ditta G, Stanfield S, Corbin D, Helinski DR. 1980. Broad host range DNA 1015 
cloning system for gram-negative bacteria: construction of a gene bank of 1016 
Rhizobium meliloti. Proc Natl Acad Sci U S A 77:7347-7351. 1017 
63. Masai E, Shinohara S, Hara H, Nishikawa S, Katayama Y, Fukuda M. 1999. 1018 
Genetic and biochemical characterization of a 2-pyrone-4,6-dicarboxylic acid 1019 
hydrolase involved in the protocatechuate 4,5-cleavage pathway of Sphingomonas 1020 
paucimobilis SYK-6. J Bacteriol 181:55-62. 1021 
64. Kaczmarczyk A, Vorholt JA, Francez-Charlot A. 2012. Markerless gene 1022 
deletion system for sphingomonads. Appl Environ Microbiol 78:3774-3777. 1023 
65. Katayama Y, Nishikawa S, Nakamura M, Yano K, Yamasaki M, Morohoshi 1024 
N, Haraguchi T. 1987. Cloning and expression of Pseudomonas paucimobilis 1025 
SYK-6 genes involved in the degradation of vanillate and protocatechuate in P. 1026 
putida. Mokuzai Gakkaishi 33:77-79. 1027 
66. Peng X, Masai E, Kasai D, Miyauchi K, Katayama Y, Fukuda M. 2005. A 1028 
second 5-carboxyvanillate decarboxylase gene, ligW2, is important for lignin-1029 
related biphenyl catabolism in Sphingomonas paucimobilis SYK-6. Appl Environ 1030 
Microbiol 71:5014-5021. 1031 
67. Yamamoto Y, Kasai D, Kamimura N, Masai E. 2012. Isolation and 1032 
characterization of bzaA and bzaB of Sphingobium sp. strain SYK-6, which 1033 
encode aromatic aldehydes dehydrogenases with different substrate preferences. 1034 
Trans GIGAKU 1:01009/01001-01006. 1035 
68. Takeuchi M, Kawai F, Shimada Y, Yokota A. 1993. Taxonomic study of 1036 
polyethylene glycol-utilizing bacteria: emended description of the genus 1037 
Sphingomonas and new descriptions of Sphingomonas macrogoltabidus sp. nov., 1038 
Sphingomonas sanguis sp. nov. and Sphingomonas terrae sp. nov. Syst Appl 1039 
Microbiol 16:227-238. 1040 
69. Studier FW, Moffatt BA. 1986. Use of bacteriophage T7 RNA polymerase to 1041 
direct selective high-level expression of cloned genes. J Mol Biol 189:113-130. 1042 
70. Bolivar F, Backman K. 1979. Plasmids of Escherichia coli as cloning vectors. 1043 
Methods Enzymol 68:245-267. 1044 
71. Figurski DH, Helinski DR. 1979. Replication of an origin-containing derivative 1045 
of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl 1046 
Acad Sci U S A 76:1648-1652. 1047 
72. Short JM, Fernandez JM, Sorge JA, Huse WD. 1988. Lambda ZAP: a 1048 
bacteriophage lambda expression vector with in vivo excision properties. Nucleic 1049 
 43 
Acids Res 16:7583-7600. 1050 
73. Yanisch-Perron C, Vieira J, Messing J. 1985. Improved M13 phage cloning 1051 
vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectors. 1052 
Gene 33:103-119. 1053 
74. Schäfer A, Tauch A, Jäger W, Kalinowski J, Thierbach G, Pühler A. 1994. 1054 
Small mobilizable multi-purpose cloning vectors derived from the Escherichia 1055 
coli plasmids pK18 and pK19: selection of defined deletions in the chromosome 1056 
of Corynebacterium glutamicum. Gene 145:69-73. 1057 
75. Masai E, Sasaki M, Minakawa Y, Abe T, Sonoki T, Miyauchi K, Katayama Y, 1058 
Fukuda M. 2004. A novel tetrahydrofolate-dependent O-demethylase gene is 1059 
essential for growth of Sphingomonas paucimobilis SYK-6 with syringate. J 1060 
Bacteriol 186:2757-2765. 1061 
76. Blatny JM, Brautaset T, Winther-Larsen HC, Karunakaran P, Valla S. 1997. 1062 
Improved broad-host-range RK2 vectors useful for high and low regulated gene 1063 
expression levels in gram-negative bacteria. Plasmid 38:35-51. 1064 
77. Masai E, Yamamoto Y, Inoue T, Takamura K, Hara H, Kasai D, Katayama 1065 
Y, Fukuda M. 2007. Characterization of ligV essential for catabolism of vanillin 1066 
by Sphingomonas paucimobilis SYK-6. Biosci Biotechnol Biochem 71:2487-1067 
2492. 1068 
   1069 
 44 
Figure Legends 1070 
FIG 1 Proposed catabolic pathway of arylglycerol--aryl ether in Sphingobium sp. 1071 
strain SYK-6. The pathway for both guaiacyl (R = H) and syringyl (R = OCH3)-type -1072 
aryl ether compounds is shown. Enzymes: LigD, LigL, and LigN, C-dehydrogenases; 1073 
LigF, LigE, and LigP, -etherases; LigG, glutathione S-transferase; HpvZ, HPV oxidase; 1074 
ALDHs, aldehyde dehydrogenases; Abbreviations: GGE, guaiacylglycerol--guaiacyl 1075 
ether; MPHPV, -(2-methoxyphenoxy)--hydroxypropiovanillone; GS-HPV, -1076 
glutathionyl--hydroxypropiovanillone; HPV, -hydroxypropiovanillone; HPS, -1077 
hydroxypropiosyringone; VAL, vanilloyl acetaldehyde; SAL, 3-(4-hydroxy-3,5-1078 
dimethoxyphenyl)-3-oxopropanal; VAA, vanilloyl acetic acid; SAA, 3-(4-hydroxy-3,5-1079 
dimethoxyphenyl)-3-oxopropanoic acid; CoA, coenzyme A; VAA-CoA, CoA derivative 1080 
of VAA. 1081 
 1082 
FIG 2 HPLC-MS analysis of HPV metabolites. Resting cells of SYK-6 (OD600 of 5.0) 1083 
and SYK-6 cell extracts (>10 kDa; 500 µg of protein/ml) were incubated with 1 mM 1084 
HPV (A and B) and 200 µM HPV (D and E), respectively. The same cell extracts (>10 1085 
kDa) were incubated with HPV in the presence of 500 µM NAD+ (G and H) and in the 1086 
presence of 500 µM NAD+ + 2 mM CoA + 2.5 mM MgSO4 + 2.5 mM ATP (J and K). 1087 
Portions of the reaction mixtures were collected at the start (A and D) and after 2 h (G 1088 
and J), 6 h (B), and 24 h (E, H, and K) of incubation, and analyzed by HPLC. ESI-MS 1089 
spectra of compounds I (negative mode), II (positive mode), III (negative mode), and IV 1090 
(positive mode) are shown in panels C, F, I, and L, respectively. An asterisk shown in 1091 
panel (I) indicates an unidentified MS fragment that appeared between retention times 1092 
of 2.0 and 7.0 min in the HPLC chromatogram (H). 1093 
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 1094 
FIG 3 HPLC-MS analysis of HPS metabolites. SYK-6 resting cells (OD600 of 5.0) and 1095 
SYK-6 cell extracts (>10 kDa; 500 µg of protein/ml) were incubated with 1 mM HPS 1096 
(A and B) and 200 µM HPS (D and E), respectively. The same cell extract (>10 kDa) 1097 
was incubated with HPS in the presence of 500 µM NAD+ (G and H). Portions of the 1098 
reaction mixtures were collected at the start (A, D, and G) and after 4 h (B) and 16 h (E 1099 
and H) of incubation, and analyzed by HPLC. Negative-ion ESI-MS spectra of 1100 
compounds V, VI, and VII are shown in panels C, F, and I, respectively. 1101 
 1102 
FIG 4 Function and role of hpvZ in SYK-6. (A and B) Conversion of 200 µM HPV by 1103 
resting cells of E. coli harboring pCold12830 and pTf16 in Tris-HCl buffer (pH 7.5) (A) 1104 
and water (B). Portions of the reaction mixtures were collected after 6 h of incubation, 1105 
and analyzed by HPLC. ESI-MS spectra of compound VIII (positive mode) is shown in 1106 
panel C. (D–F) Conversions of 200 M HPV (D), GGE (E), and HPS (F) by resting 1107 
cells of SYK-6 (open symbols) and SME059 (closed symbols). Circles, triangles, and 1108 
diamonds indicate the concentrations of HPV, GGE, and HPS, respectively. (G) 1109 
Complementation of SME059 with pJB12830. Cells of SYK-6 harboring pJB864 1110 
(circles), SME059 harboring pJB864 (triangles), and SME059 harboring pJB12830 1111 
(diamonds) were incubated with 200 µM HPV. Experiments shown in panels D–G were 1112 
performed in triplicate, and the data represent the averages ± standard deviations. 1113 
 1114 
FIG 5 Identification of ALDH genes involved in VAL conversion. (A) Resting cells of 1115 
E. coli carrying each of the 23 SYK-6 ALDH genes (OD600 of 1.0) were incubated with 1116 
100 M HPV in the presence of resting cells of E. coli harboring pCold12830 and 1117 
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pTf16 (OD600 of 5.0). The amounts of VAA produced in the reaction mixtures 1118 
containing each of the ALDH gene-expressing cells are shown as the relative ratio to 1119 
that in the reaction mixture containing SLG_20400-expressing cells. ND, VAA was not 1120 
detected. (B) Time course of the production of VAA during incubation of 100 µM HPV 1121 
with cells of E. coli harboring pCold12830 and pTf16 (OD600 of 10.0) and E. coli 1122 
carrying following ALDH genes (OD600 of 1.0): SLG_20400 (closed circles), 1123 
SLG_07270 (closed triangles), bzaB (closed squares), SLG_12800 (closed diamonds), 1124 
SLG_18210 (open circles), bzaA (open triangles), and SLG_31150 (open squares). E. 1125 
coli cells harboring pET-21a(+) was used as a negative control (open diamonds). (C) 1126 
Accumulation of VAL-Tris during incubation of 1 mM HPV with cells of E. coli 1127 
harboring pCold12830 and pTf16 (OD600 of 10.0) and the following mutants of the 1128 
ALDH genes (OD600 of 0.5): SME061 (SLG_20400; closed circles), SME045 (bzaB; 1129 
closed squares), SME092 (SLG_07270; closed triangles), and SME031 1130 
(SLG_12800; closed diamonds). SYK-6 cells were used as a control (open diamonds). 1131 
These experiments were performed in triplicate, and the data represent the averages ± 1132 
standard deviations. 1133 
 1134 
FIG 6 Conversion of VAA by desV ligV double mutant. Resting cells of desV ligV 1135 
double mutant (SME077) were incubated with 100 µM VAA (A–C) and 1 mM ferulate 1136 
(D–F). Portions of the reaction mixtures were collected at the start (A and D) and after 2 1137 
h (B and E) and 4 h (C and F) of incubation, and analyzed by HPLC using two different 1138 
analytical conditions described in the materials and methods. The retention times of 1139 
vanillin separated under the analytical conditions for the reaction mixtures of VAA (A–1140 
C) and ferulate (D–F) were 2.9 and 2.4 min, respectively. 1141 
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FIG 7 Synthetic routes to HPS and HPV.1142 
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TABLE 1 Substrate range of HpvZ 
Compounds 
Specific activitya 
(nmol·min–1·mg–1) 
HPV 26 ± 6 
HPS 40 ± 5 
coniferyl alcohol 8.0 ± 0.4 
sinapyl alcohol 52 ± 7 
cinnamyl alcohol 40 ± 9 
3-(4-hydroxyphenyl)-1-propanol 
homovanillyl alcohol 
8 ± 2 
NDb 
vanillyl alcohol 
GGE 
MPHPV 
DCA 
ND 
ND 
ND 
13 ± 2 
DCA-C ND 
 
aThe membrane fraction of hpvZ expressing E. coli (300 µg of protein/ml) was 
incubated with 200 µM substrate in the presence of 500 µM PMS. The data represent 
the averages ± standard deviations of three independent experiments. 
bND, not detected 
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TABLE 2 Strains and plasmids used in this study 
Strains or plasmids Relevant characteristic(s)a Reference or source 
Sphingobium sp. 
SYK-6 
SME009 
SME031 
SME045 
SME059 
SME061 
SME077 
SME092 
 
Sphingomonas sanguinis 
IAM 12578 
 
Escherichia coli 
BL21(DE3) 
 
HB101 
NEB 10-beta 
 
 
Plasmids 
pVK100 
pRK2013 
pT7Blue 
pBluescript II KS(+)   
and SK(+) 
pUC19 
pET-16b 
pET-21a(+) 
pCold I 
pTf16 
pK18mobsacB 
pK19mobsacB 
pIK03 
pJB864 
pAK405 
pSA53 
pSA88 
pSA684 
pT7B12830 
pCold12830 
pBH37F 
pUC12830 
pUC12830K 
pKmb12830K 
pJB12830 
pLVH 
 pT21-0727  
 pT21-0761  
 pT21-0779  
 pT21-0940  
 pT21-0951  
 pT21-0992  
 pT21-1141 
 pT21-1202  
 pT21-1219  
 pT21-1280  
 pT21-1821  
 pT21-2040  
 
Wild type; Nalr Smr 
SYK-6 derivative; ferA::kan; Nalr Smr Kmr 
SYK-6 derivative; SLG_12800::kan; Nalr Smr Kmr 
SYK-6 derivative; bzaB::tet; Nalr Smr Tcr 
SYK-6 derivative; hpvZ::kan; Nalr Smr Kmr 
SYK-6 derivative; SLG_20400; Nalr Smr 
SYK-6 derivative; desV::cat ligV::kan; Nalr Smr Cmr Kmr 
SYK-6 derivative; SLG_07270::kan; Nalr Smr Kmr  
 
Nalr 
 
 
 
F- ompT hsdSB(rB
- mB
-) gal dcm (DE3); T7 RNA polymerase gene under the control of the lacUV5 
promoter 
recA13 supE44 hsd20 ara-14 proA2 lacY1 galK2 rpsL20 xyl-5 mtl-1 
araD139 (ara-leu)7697 fhuA lacX74 galK (ϕ80lacZ ΔM15) recA1 endA1 nupG rpsL (Smr) 
(mrr-hsdRMS-mcrBC)  
 
 
Broad-host-range cosmid vector; Kmr Tcr 
Tra+ Mob+ ColE1 replicon; Kmr 
Cloning vector; Apr 
Cloning vector; Apr 
 
Cloning vector; Apr 
Expression vector; T7 promoter, Apr 
Expression vector; T7 promoter, Apr 
Expression vector; cspA promoter, Apr 
Expression vector for tig; araB promoter; Cmr 
oriT sacB; Kmr 
oriT sacB; Kmr 
KS(+) with a 1.3-kb EcoRV fragment carrying kan of pUC4K; Apr Kmr 
RK2 broad-host-range expression vector; Apr Cbr Pm xylS 
Plasmid for allelic exchange and markerless gene deletions in Sphingomonads; Kmr 
pVK100 with partially SalI-digested fragments of SYK-6 carrying hpvZ  
pVK100 with partially SalI-digested fragments of SYK-6 carrying hpvZ 
pVK100 with partially SalI-digested fragments of SYK-6 carrying hpvZ 
pT7Blue with a 1.7-kb PCR amplified fragment carrying hpvZ 
pCold I with a 1.7-kb NdeI-BamHI fragment carrying hpvZ from pT7B12830 
SK(+) with a 3.7-kb HindIII fragment carrying hpvZ from pSA53 
pUC19 with a 2.0-kb SalI fragment of pBH37F 
pUC12830 with a 1.3-kb SalI-BamHI fragment of pIK03 carrying kan 
pK19mobsacB with a 3.1-kb SalI fragment of pUC12830K 
pJB864 with a 2.3-kb BamHI-SacII (blunted) fragment carrying hpvZ from pBH37F 
pET-21a(+) with a 1.9-kb NdeI-XhoI fragment carrying ligV 
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_07270  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_07610  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_07790  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_09400  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_09510  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_09920  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_11410 
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_12020  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_12190   
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_12800  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_18210  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_20400  
 
(65) 
(36) 
(66) 
(67) 
This study 
This study 
(51) 
This study 
 
(68) 
 
 
 
(69) 
 
(70) 
New England 
Biolabs 
 
 
(62) 
(71) 
Novagen 
(72) 
 
(73) 
Novagen 
Novagen 
Takara Bio 
Takara Bio 
(74) 
(74) 
(75) 
(76) 
(64) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
(77) 
(51) 
(51) 
(51) 
(51) 
(51) 
(51) 
(51) 
(51) 
(51) 
(51) 
(51) 
(51) 
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a Kmr, Nalr, Smr, Apr, Tcr, Cmr, and Cbr, resistance to kanamycin, nalidixic acid, streptomycin, ampicillin, tetracycline, 
chloramphenicol, and carbenicillin, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 pT21-2721  
 pT21-2791  
 pT21-2792  
 pT21-2815  
 pT21-2832  
 pT21-3115  
 pT21-3224  
 pT21-3494 
pT21-3812 
pT21-p0068 
pKS0727 
pKmb07270 
pKmb07270K 
 
pAK20400 
pE16FA 
pE16FB 
pE16FB2 
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_27210  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying bzaA  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying bzaB  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_28150  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_28320  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_31150  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_32240  
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_34940 
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_38120 
pET-21a(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_p_00680 
KS(+) with a 1.5-kb NdeI-BamHI fragment carrying SLG_07270  
pK18mobsacB with a 1.5-kb HindIII-XbaI carrying SLG_07270 from pKS0727 
pKmb07270 with a 1.3-kb EcoRV fragment carrying kan from pIK03  
into NruI site of SLG_07270 
pAK405 with a 2.3-kb deletion cassette carrying up- and downstream regions of SLG_20400  
pET-16b with a 2.2-kb NdeI-BamHI fragment carrying ferA 
pET-16b with a 0.9-kb NdeI-BamHI PCR amplified fragment carrying ferB 
pET-16b with a 1.1-kb NdeI-BamHI PCR amplified fragment carrying ferB2 
(51) 
(51) 
(51) 
(51) 
(51) 
(51) 
(51) 
(51) 
(51) 
(51) 
(51) 
This study 
This study 
 
This study 
(31) 
This study 
This study 
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TABLE 3 Primer sequences used for construction of plasmids and colony PCR 
Plasmid or strain Primer Sequence (5 to 3) 
Construction of plasmids 
pT7B12830 
 
pAK20400 
 
 
 
pE16FB 
 
pE16FB2 
 
 
Colony PCR 
SME061 
 
12830_pT7B_F 
12830_pT7B_R 
dis20400_Top_F 
dis20400_Top_R 
dis20400_Bot_F 
dis20400_Bot_R 
ferB_exp_F 
ferB_exp_R 
ferB2_exp_F 
ferB2_exp_R 
 
 
dis20400_conf_F 
dis20400_Bot_R 
 
AGACAGGCATATGGTTGATG  
GGGCGGCATGGATCCGC  
CGGTACCCGGGGATCCGGCTTCGGTGACAATCAT 
ATGTCCGTGGTGTTCTGCGT 
ACGCAGAACACCACGGACATTCCTCCCCGTGATGACCTAT 
CGACTCTAGAGGATCGTGGCGGCATCAACATATCG 
GGAAAATCATATGTCCGAGG 
ATACTGGCGGATCCAGCC 
TGAGGATGCATATGTCGGATG 
GCCGGATCCCGGAATGC 
 
 
CCTTCATCGCCATCATAAAT 
CGACTCTAGAGGATCGTGGCGGCATCAACATATCG 
 
